<SEC-DOCUMENT>0001493152-25-024996.txt : 20251125
<SEC-HEADER>0001493152-25-024996.hdr.sgml : 20251125
<ACCEPTANCE-DATETIME>20251125170024
ACCESSION NUMBER:		0001493152-25-024996
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20251125
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251125
DATE AS OF CHANGE:		20251125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIXTE BIOTECHNOLOGY HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001335105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				202903526
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39717
		FILM NUMBER:		251522397

	BUSINESS ADDRESS:	
		STREET 1:		433 PLAZA REAL
		STREET 2:		SUITE 275
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33432
		BUSINESS PHONE:		310 203 2902

	MAIL ADDRESS:	
		STREET 1:		433 PLAZA REAL
		STREET 2:		SUITE 275
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33432

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SRKP 7 INC
		DATE OF NAME CHANGE:	20050803
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:LIXT="http://lixte.com/20251125">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_LIXT_lixte.com_20251125 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20251125_20251125 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001335105 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000003" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000004" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000005" name="dei:EntityCentralIndexKey">0001335105</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lixt-20251125.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-11-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001335105</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-25</xbrli:startDate>
        <xbrli:endDate>2025-11-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001335105</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LIXT:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-25</xbrli:startDate>
        <xbrli:endDate>2025-11-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001335105</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LIXT:WarrantsToPurchaseCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-25</xbrli:startDate>
        <xbrli:endDate>2025-11-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_909_edei--DocumentType_c20251125__20251125_z7ETmczJNPU8"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURSUANT
TO SECTION 13 OR 15(d) OF THE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20251125__20251125_zdt4ft4fyW6e"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">November 25, 2025</ix:nonNumeric></span> (November 21, 2025)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_903_edei--EntityRegistrantName_c20251125__20251125_zkzZvSRIonL8"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000012" name="dei:EntityRegistrantName">LIXTE
BIOTECHNOLOGY HOLDINGS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20251125__20251125_zERW9JUhmbAa"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityFileNumber_c20251125__20251125_z6oGVHsze8if"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000014" name="dei:EntityFileNumber">001-39717</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20251125__20251125_zLXBJ5MgwvNe"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000015" name="dei:EntityTaxIdentificationNumber">20-2903526</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityAddressAddressLine1_c20251125__20251125_zLuVcjULu4re"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000016" name="dei:EntityAddressAddressLine1">680
East Colorado Boulevard</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20251125__20251125_zexWqLg2viBk"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000017" name="dei:EntityAddressAddressLine2">Suite 180</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityAddressCityOrTown_c20251125__20251125_z4oWzm77peO5"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000018" name="dei:EntityAddressCityOrTown">Pasadena</ix:nonNumeric></span>,
<span id="xdx_900_edei--EntityAddressStateOrProvince_c20251125__20251125_zvElU9TzTsQ3"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt-sec:stateprovnameen" id="Fact000019" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20251125__20251125_znZCGXrkSQl1"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000020" name="dei:EntityAddressPostalZipCode">91101</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--CityAreaCode_c20251125__20251125_zxPA0NfsMEi9"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000021" name="dei:CityAreaCode">(631)</ix:nonNumeric></span>
<span id="xdx_906_edei--LocalPhoneNumber_c20251125__20251125_zdDATSia4tG2"><ix:nonNumeric contextRef="AsOf2025-11-25" id="Fact000022" name="dei:LocalPhoneNumber">830-7092</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (See General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20251125__20251125_zROJZ0YGebsi"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act of 1933 (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20251125__20251125_znOQ1Fukee81"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementTenderOffer_c20251125__20251125_zN3WTdn8tmP4"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20251125__20251125_zO8bai8h18ff"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(e) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20251125__20251125__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_z78e1reRwRob"><ix:nonNumeric contextRef="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value
    $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20251125__20251125__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zLN8icE6aNrh"><ix:nonNumeric contextRef="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember" id="Fact000028" name="dei:TradingSymbol">LIXT</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--SecurityExchangeName_c20251125__20251125__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zFn6C6Uk0Iwc"><ix:nonNumeric contextRef="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The NASDAQ Stock Market,
    LLC</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20251125__20251125__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockParValue0.0001PerShareMember_zViE5MNDAEK6"><ix:nonNumeric contextRef="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" id="Fact000030" name="dei:Security12bTitle">Warrants to Purchase Common
    Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20251125__20251125__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockParValue0.0001PerShareMember_zRYe9V0y60Uf"><ix:nonNumeric contextRef="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" id="Fact000031" name="dei:TradingSymbol">LIXTW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SecurityExchangeName_c20251125__20251125__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockParValue0.0001PerShareMember_z9t3OnRQWUPd"><ix:nonNumeric contextRef="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">The NASDAQ Stock Market,
    LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20251125__20251125_zszc2W3gl0B7"><ix:nonNumeric contextRef="AsOf2025-11-25" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="font: 10pt Times New Roman, Times, Serif; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr></table><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
1.01. Entry Into a Material Definitive Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 2.01 below regarding the Share Exchange Agreement (as defined below) is incorporated by reference in this
Item 1.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
2.01. Completion of Acquisition or Disposition of Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
Exchange Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 21, 2025, Lixte Biotechnology Holdings, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;), entered into a Share
Exchange Agreement (the &#8220;<b>Share Exchange Agreement</b>&#8221;) with Orbit Capital Inc., a Cayman Islands corporation (the &#8220;<b>Seller</b>&#8221;),
and Liora Technologies Europe Ltd., a corporation organized under the laws of England and Wales which is wholly-owned by the Seller (the
&#8220;<b>Liora</b>&#8221;). Pursuant to the Share Exchange Agreement, the Company agreed to purchase from Seller all of the issued and
outstanding ordinary shares of Liora (the &#8220;<b>Shares </b>&#8221;) in exchange for the Consideration set forth below (the &#8220;<b>Share
Exchange</b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liora
was formed on October 7, 2025 and, on November 11, 2025, acquired certain assets from Advanced Oncotherapy PLC pursuant to an asset purchase
agreement. These assets include intellectual property and goodwill, technology, hardware, software, digital assets and all of the other
assets, property or rights relating to the LIGHT (Linac Image Guided Hadron Therapy), a proton-based radiotherapy solution, as identified
on Schedule 1 attached to the Share Exchange Agreement. Liora&#8217;s equipment and operations are located at the Daresbury Laboratory
in Warrington, United Kingdom pursuant to a lease agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the closing, the Company agreed to pay the following consideration (the &#8220;<b>Consideration</b>&#8221;) in exchange for the Shares:
(i) issue to Seller 2,700 shares of the Company&#8217;s Series C Preferred Stock, $1,000 stated value per share (the &#8220;<b>Series
C Preferred Stock</b>&#8221;) having such rights and preferences as set forth in the certificate of designation included as Exhibit 1
in the Share Exchange Agreement, which are non-voting and shall be convertible into an aggregate of 2,700,000 shares of the Company&#8217;s
common stock, subject to a 19.99% conversion limitation until the Company obtains shareholder approval; (ii) pay to Seller 10.56 Bitcoin
and 300 Ethereum; (iii) pay to Seller $440,000 in cash; and (iv) enter into a royalty agreement with Seller that entitles the Seller
to receive a royalty equal to ten percent (10%) of net revenues generated from the operation, use, licensing, monetization or sale of
and the LIGHT equipment (the &#8220;<b>Company Equipment</b>&#8221;), up to a maximum aggregate royalty payment of $45,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Share Exchange is subject to customary closing conditions, including the accuracy of representations and warranties, compliance
by the parties with their covenants, the receipt of required consents and governmental approvals, the continued validity of certain prior
transactions relating to Liora&#8217;s acquisition of its assets, and the Company&#8217;s continued listing on The Nasdaq Global Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Agreement also contains customary representations, warranties and covenants of the parties. These provisions include, among other things,
covenants relating to the operation of the Company and Liora prior to closing, requirements relating to regulatory and third-party approvals,
and post-closing cooperation obligations, including support for any financial audits required by applicable law. The Agreement also provides
for mutual indemnification obligations. The Company is required to seek shareholder approval for the full conversion of the Series C
Preferred Stock at its 2026 annual meeting of shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Share Exchange was consummated on November 24, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="font: 10pt Times New Roman, Times, Serif; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr></table><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty
Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 24, 2025, the Company entered into a Royalty Agreement with Orbit Capital Inc. (the &#8220;<b>Royalty Holder</b>&#8221;) in
connection with the Share Exchange Agreement among the Company, the Royalty Holder, and Liora Technologies Europe Ltd. Pursuant to the
Royalty Agreement, the Company agreed to pay the Royalty Holder a royalty based on revenues derived from the Company Equipment acquired
through the Share Exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Royalty Agreement, beginning on the first date on which the Company or any of its affiliates generates Net Revenue and continuing
until the agreement terminates in accordance with its terms, the Company will pay to the Royalty Holder a royalty equal to ten percent
(10%) of Net Revenue. &#8220;<b>Net Revenue</b>&#8221; consists of gross revenue received from the operation, use, licensing, monetization
or sale of the Company Equipment, less direct and indirect expenses and costs attributable to such revenues, determined in accordance
with U.S. GAAP. The aggregate amount of royalties payable under the agreement may not exceed a maximum royalty payment cap of $45,000,000.
Once the Company provides an officer&#8217;s certificate confirming that cumulative royalty payments have reached the royalty payment
cap, the agreement automatically terminates without further action by either party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the commencement of Net Revenue, the Company must calculate the royalty on a quarterly basis. After releasing its quarterly financial
results, or within sixty days after quarter end if public reporting is not required, the Company will deliver to the Royalty Holder an
operations report setting forth the Net Revenue for the applicable period, the resulting royalty calculation, and cumulative royalty
payments to date. Royalty payments are due within five business days after delivery of the report. The Royalty Holder may review and
audit the Company&#8217;s records relating to the calculation of royalties, subject to certain procedural requirements and time limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of each of the Share Exchange Agreement and the Royalty Agreement do not purport to be complete and are each qualified
in their entirety by reference to the full text of the forms of the Share Exchange Agreement and the Royalty Agreement, copies of which
are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K (&#8220;<b>Form 8-K</b>&#8221;) and incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used but not otherwise defined in Item 2.01 of this Form 8-K have the respective meanings ascribed thereto by the Share Exchange
Agreement and the Royalty Agreement, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
3.02. Unregistered Sales of Equity Securities.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 2.01 and Item 5.03 of this Form 8-K is hereby incorporated by reference into this Item 3.02 in its entirety.
The Series C Preferred Stock has not been registered under the Securities Act and has been issued in reliance on an exemption from the
registration requirements of the Securities Act afforded by Section 4(a)(2) thereof. The Series C Preferred Stock may not be offered
or sold in the United States in the absence of an effective registration statement or exemption from applicable registration requirements.
No statement in this document or the attached exhibits is an offer to purchase or a solicitation of an offer to sell securities. No offer,
solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 24, 2025, the Company filed a Certificate of Designations of Preferences, Rights and Limitations of Series C Convertible Preferred
Stock (the &#8220;<b>Certificate of Designation</b>&#8221;) with the Secretary of State of the State of Delaware. The Certificate of
Designation created a new series of preferred stock designated as Series C Convertible Preferred Stock, consisting of 2,700 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="font: 10pt Times New Roman, Times, Serif; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr></table><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series C Preferred Stock has a stated value of $1,000 per share and does not accrue dividends. Holders of the Series C Preferred Stock
do not have voting rights except where required by Delaware law or where an amendment would adversely affect the rights or preferences
of the Series C Preferred Stock. In such cases, the Company may not amend its charter documents or alter the rights of the Series C Preferred
Stock without the affirmative vote of the holders of a majority of the outstanding shares of Series C Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a liquidation, dissolution, or winding up of the Company, the Series C Preferred Stock ranks senior to junior securities, on parity with
the Company&#8217;s common stock and any series of preferred stock that ranks equally, and junior to any series of preferred stock expressly
designated as senior. Each holder is entitled to receive an amount equal to the stated value before any distribution is made to junior
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Series C Preferred Stock is convertible, at the option of the holder, into 1,000 shares of common stock. Conversions are subject
to certain limitations, including a 4.99% beneficial ownership limitation, which a holder may increase or decrease upon 61 days&#8217;
prior notice, provided that it may not exceed 19.99% of the Company&#8217;s outstanding common stock post-issuance unless the Company
obtains shareholder approval as required under the applicable Nasdaq listing rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to reserve a sufficient number of shares of common stock for issuance upon conversion of the Series C Preferred Stock,
and any conversion shares issued will be fully paid and non-assessable. The Series C Preferred Stock is not subject to redemption at
the option of either the Company or the holders; provided, however, that the foregoing shall not limit the ability of the Company to
purchase or otherwise deal in such shares to the extent otherwise permitted hereby and by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Certificate of Designation does not purport to be complete and is qualified in its entirety by reference
to the full text of the Certificate of Designation, a copy of which is filed as Exhibit 3.1 to this Form 8-K and is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in Item 5.03 of this Form 8-K but not otherwise defined have the meaning set forth in the Certificate of Designation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
7.01 Regulation FD Disclosure</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 25,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025,
the Company i<span style="background-color: white">ssued a press release announcing the closing of the Share Exchange</span>, a copy
of which is attached hereto as Exhibit 99.1 and incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for
the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that Section, nor shall it be deemed subject to the requirements of Item 10 of Regulation S-K, nor shall it be
deemed incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or
after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall
not be deemed an admission as to the materiality of any such information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits. The following exhibits are filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; vertical-align: top; width: 0.5in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 0pt; width: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><a href="ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock filed with the Delaware Secretary of State on November 21, 2025</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Exchange Agreement, dated November 21, 2025, by and among the Company, Orbit Capital Inc., and Liora Technologies Europe Ltd.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalty Agreement, dated November 24, 2025, by and among the Company and Orbit Capital Inc.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated November 25, 2025</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the
    inline XBRL Document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="font: 10pt Times New Roman, Times, Serif; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr></table><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 25, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIXTE
    BIOTECHNOLOGY HOLDINGS, INC.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>By:</i></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Geordan
    Pursglove&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geordan Pursglove</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="font: 10pt Times New Roman, Times, Serif; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr></table><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJydkE1uwjAQhU/AHUZRlwhs92eRXRtRVBWqCBDtdghDsUg80dihcKTesk5S1E03rWXJsmfe9944SYbJlB9tSQJvD4sZrKiqSwwEC9qRkCsodmRPzynEc0Hv1gdBF7rrRZhx1FDU3I3MJr53nUfraZuC1mNzMza3oK5TrSGfJ4O2nrHb2S25YLEEdFvIhWuxFFDOPWGFJ3ZcnTunNYm37CJupPryJxilDbzwET9YDh5msywZDLs1SKbCTR27JqdArlXCpKQq2vle/bO7NEXjA1fpK0o7m19x3kixR09xsordMnBxyFHWWDakRkopnZMs9yg0p2pDEhFaGaPV/Xe6CwkCw4UFPQw62hBqFDi2QLjqkVDHr/Qt9Jdo/w3yZ88vosifGA== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIXTE
BIOTECHNOLOGY HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATIONS OF PREFERENCES,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
C CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to Section 151 of the General Corporation Law of the State of Delaware, Lixte Biotechnology Holdings, Inc., a corporation organized and
existing under the General Corporation Law of the State of Delaware (the &ldquo;<B>Corporation</B>&rdquo;), in accordance with the provisions
of Section 103 thereof, does hereby submit the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Certificate of Incorporation of the Corporation (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;) authorizes the issuance of
up to 10,000,000 shares of preferred stock, par value $0.0001 per share, of the Corporation (&ldquo;<B>Preferred Stock</B>&rdquo;), and
expressly authorizes the Board of Directors of the Corporation (the &ldquo;<B>Board</B>&rdquo;), subject to limitations prescribed by
law, to issue in one or more classes or one or more series within any class, and such classes or series shall have such voting powers,
full or limited, or no voting powers, and such designations, preferences, limitations or restrictions as the Board may determine, from
time to time; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,</B>
it is the desire of the Board to establish and fix the number of shares to be included in a new series of Preferred Stock and the designation,
rights, preferences, and limitations of the shares of such new series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, BE IT RESOLVED</B>, that the Board does hereby provide for the issue of a series of Preferred Stock and does hereby in this
Certificate of Designation (the &ldquo;<B>Certificate of Designation</B>&rdquo;) establish and fix and herein state and express the designation,
rights, preferences, powers, restrictions, and limitations of such series of Preferred Stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, par value $0.0001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion</U>&rdquo;
shall have the meaning set forth in Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of the Series C Preferred Stock
in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Junior
Securities</U>&rdquo; means any class of securities that is specifically designated as junior to the Series C Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means November 21, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
C Preferred Stock</U>&rdquo; means the Corporation&rsquo;s Series C Convertible Preferred Stock, par value $0.0001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; means the stated value of the Series C Convertible Preferred Stock, which shall be $1,000 per share, subject to adjustment
for stock splits, dividends, combinations and related transactions as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means approval by a majority of the votes cast by the Corporation&rsquo;s shareholders for the issuance of Conversion
Shares in excess of the 19.99% Exchange Cap in accordance with the applicable rules of The Nasdaq Stock Market LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Designation and Amount</U>. Two thousand and seven hundred (2,700) shares of Preferred Stock of the Corporation are hereby designated
as &ldquo;Series C Convertible Preferred Stock.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>No Dividends</U>. No dividends shall be paid on shares of Series C Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Voting Rights</U>. The holders of shares of Series C Preferred Stock (each a &ldquo;<B>Holder</B>&rdquo; and collectively, the
&ldquo;<B>Holders</B>&rdquo;) shall not be entitled to any voting rights, other than any vote required by law or the Certificate of Incorporation.
However, for as long as any shares of Series C Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote
of the Holders of a majority of the then outstanding shares of the Series C Preferred Stock, (i) alter or change adversely the powers,
preferences or rights given to the Series C Preferred Stock or alter or amend this Certificate of Designation, (ii) amend its certificate
of incorporation or other charter documents in any manner that adversely affects any rights of the Holders of Series C Preferred Stock,
or (iii) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Rank; Liquidation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
With respect to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary,
all shares of Series C Preferred Stock shall rank: (i) senior to all Junior Securities; (ii) on parity with the Common Stock and any
other class or series of Preferred Stock of the Corporation that, by its terms, ranks on parity with the Series C Preferred Stock or
does not specifically rank senior to the Series C Preferred Stock (collectively, the &ldquo;<B>Parity Securities</B>&rdquo;), and (iii)
rank junior to any class or series of Preferred Stock of the Corporation, that, by its terms, ranks senior to the Series C Preferred
Stock (collectively, the &ldquo;<B>Senior Securities</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &ldquo;<B>Liquidation</B>&rdquo;),
each Holder shall be entitled, together pro rata with the holders of Parity Securities, to be paid out of the assets of the Corporation
available for distribution to its stockholders, before any payment shall be made to the holders of Junior Securities by reason of their
ownership thereof, an amount in cash equal to the Stated Value of all shares of Series C Preferred Stock held by such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. <U>Conversion</U><B>.</B> Holders of Series C Preferred Stock shall have the following rights with respect to the conversion (&ldquo;<B>Conversion</B>&rdquo;)
of the Series C Preferred Stock into shares of Common Stock:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Conversions at Option of Holder</U>. Subject to and in compliance with the provisions of this Section 6, upon the Original Issue Date,
each share of Series C Preferred Stock may, at the option of the Holder, be converted into fully paid and non-assessable shares of Common
Stock, as set forth in this Section 6, upon notice (a &ldquo;<B>Notice of Conversion</B>&rdquo;) to the Corporation. The Holders shall
effect conversions by providing the Corporation with a Notice of Conversion that shall specify the number of shares of Series C Preferred
Stock to be converted, the number of shares of Series C Preferred Stock owned prior to the conversion at issue, the number of shares
of Series C Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which
date may not be prior to the date the Holder delivers such Notice of Conversion to the Corporation (the &ldquo;<B>Conversion Date</B>&rdquo;).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to
the Corporation is deemed delivered hereunder. To effect conversions, as the case may be, of shares of Series C Preferred Stock, a Holder
shall not be required to surrender the certificate(s) representing such shares of Series C Preferred Stock to the Corporation unless
all of the shares of Series C Preferred Stock represented thereby are so converted, in which case the Holder shall deliver the certificate
representing such shares of Series C Preferred Stock promptly following the Conversion Date at issue. The Corporation shall deliver,
or cause to be delivered, to such Holder, certificates or book-entry statements representing the Conversion Shares promptly, but in no
event more than two (2) Trading Days following the applicable Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Conversion Shares</U>. Each share of Series C Preferred Stock shall be convertible into 1,000 Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Limitations of Conversion</U>. Notwithstanding anything to the contrary contained herein, the number of Conversion Shares that may
be acquired by the Holder upon conversion of the Series C Preferred Stock (or otherwise in respect hereof) shall be limited to the extent
necessary to ensure that, following such conversion (or other issuance), the total number of shares of Common Stock then beneficially
owned by such Holder and its affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated with the
Holder&rsquo;s for purposes of Section 13(d) of the Securities and Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
does not exceed 4.99% of the total number of issued and outstanding shares of Common Stock (including for such purpose the shares of
Common Stock issuable upon such conversion) (the &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo;), and such Conversion Shares that
may otherwise be acquired by the Holder upon such conversion (or other issuance) shall be held in abeyance for the Holder until such
time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). For such purposes,
beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. The Holder, upon not less than 61 days&rsquo; prior notice to the Corporation, may increase or decrease the beneficial ownership
limitations provision of this Section, provided that the beneficial ownership limitation in no event exceeds 19.99% of the number of
shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of the
Series C Preferred Stock held by the Holder and the provisions of this Section shall continue to apply. Any such increase or decrease
will not be effective until the 61st day after such notice is delivered to the Corporation. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this Section to correct this paragraph (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor Holder. Notwithstanding anything to the contrary herein, the Corporation shall not issuance any Conversion
Shares pursuant to this Section 6 to the extent (but only to the extent) that after giving effect to such issuance of Conversion Shares,
the aggregate number of Conversion Shares issued under this Certificate of Designation would exceed 19.99% of the aggregate number of
shares of Common Stocks issued and outstanding as of the execution date of this Certificate of Designation, which number shall be reduced,
on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions
that may be aggregated with the issuance of the Conversion Shares under the applicable rules of the Trading Market (such maximum number
of shares, the &ldquo;<B>Exchange Cap</B>&rdquo;) unless the Company has obtained Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Stock Splits or Combination</U>. If the Corporation, at any time after the Original Issue Date and while at least one share of Series
C Preferred Stock is outstanding: (i) subdivides outstanding shares of Common Stock into a larger number of shares, (ii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iii) issues by reclassification
of shares of Common Stock any shares of capital stock of the Corporation, then in each case the Conversion Shares shall be multiplied
by a fraction of which (x) the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and (y) the denominator shall be the number of shares of Common Stock outstanding immediately after such
event. Any adjustment made pursuant to this Section shall become effective immediately after the effective date of the applicable event
described in subsections (i) through (iii) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Restrictions</U>. The Holder acknowledges that the Conversion Shares acquired upon the conversion of the Series C Preferred Stock,
if not registered or may then be resold pursuant to Rule 144, will have restrictions upon resale imposed by state and federal securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Calculations</U>. All calculations under this Section 6 shall be made to the nearest cent or the nearest 1/100<SUP>th</SUP> of a share,
as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Reservation of Shares.</U> The Corporation covenants and agrees that any Conversion Shares issued upon the conversion of the Series
C Preferred Stock will, upon issuance, be validly issued and outstanding, fully paid and non-assessable, and free from all taxes, liens
and charges with respect to the issuance thereof. The Corporation further covenants and agrees that the Corporation will at all times
have authorized and reserved a sufficient number of shares of its Common Stock to provide for issuance of the Conversion Shares upon
the conversion of the Series C Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Payment of Taxes</U>. The Corporation and its paying agent shall be entitled to withhold taxes on all payments on the Series C Preferred
Stock and Conversion Shares to the extent required by law. Prior to the date of any such payment, each Holder shall deliver to the Corporation
or its paying agent a duly executed, valid, accurate and properly completed Internal Revenue Service Form W-9 or an appropriate Internal
Revenue Service Form W-8, as applicable. The Corporation shall pay any and all documentary, stamp and similar issue or transfer tax due
on (A) the issue of the Series C Preferred Stock and (B) the issue of Conversion Shares; provided, however, in the case of any conversion
of Series C Preferred Stock, the Corporation shall not be required to pay any tax or duty that may be payable in respect of any transfer
involved in the issue and delivery of Conversion Shares in a name other than that of the Holder of the shares to be converted, and no
such issue or delivery shall be made unless and until the person requesting such issue has paid to the Corporation the amount of any
such tax or duty, or has established to the satisfaction of the Corporation that such tax or duty has been paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Status as Stockholder</U>. Upon each conversion of shares of Series C Preferred Stock, (i) such shares of Series C Preferred Stock
being converted shall automatically convert into shares of Common Stock and (ii) the applicable Holder&rsquo;s rights as a holder of
such converted shares of Series C Preferred Stock shall cease and terminate, excepting only the right to receive certificates or book-entry
documentation for such shares of Common Stock in the manner provided herein and to any remedies provided herein or otherwise available
at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation.
In all cases, each applicable Holder shall retain all of its rights and remedies for the Corporation&rsquo;s failure to convert Series
C Preferred Stock in accordance with terms of this Certificate of Designation subject to Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. <U>Reacquired Shares</U>. Any shares of Series C Preferred Stock purchased or otherwise acquired by the Corporation in any manner
whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation become
authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of preferred stock to be created by resolution
or resolutions of the Board of Directors, subject to the conditions and restrictions on issuance set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.&#8239;<U>Redemption</U>. The shares of Series C Preferred Stock shall not be redeemable at the option of the Corporation or the Holder
thereof; <U>provided</U>, <U>however</U>, that the foregoing shall not limit the ability of the Corporation to purchase or otherwise
deal in such shares to the extent otherwise permitted hereby and by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED,</B> that such determination of the designation, rights, preferences and limitations relating to the Series C Preferred Stock,
was duly made by the Board of Directors pursuant to the provisions of the Certificate of the Incorporation, and in accordance with Section
151 of Title 8 of the Delaware General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Designation to be duly executed to be effective November 21, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lixte Biotechnology Holdings, Inc.,
    a Delaware corporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Geordan Pursglove </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geordan
    Pursglove</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE
EXCHANGE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>among</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ORBIT
CAPITAL INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIORA
TECHNOLOGIES EUROPE LTD.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIXTE
BIOTECHNOLOGY HOLDINGS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>dated
as of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>November
21, 2025</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE
EXCHANGE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Share Exchange Agreement (this &ldquo;<B>Agreement</B>&rdquo;), dated as of November 21, 2025, is entered into by and among Orbit Capital
Inc., a Cayman Islands corporation (the &ldquo;<B>Seller</B>&rdquo;), Liora Technologies Europe Ltd., a corporation organized under the
laws of England and Wales which is wholly-owned by the Seller (the &ldquo;<B>Company</B>&rdquo;), and Lixte Biotechnology Holdings, Inc.,
a Delaware corporation (&ldquo;<B>PubCo</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company was formed on October 7, 2025 as a private company with the Registrar of Companies for England and Wales;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
effective as of November 11, 2025, the Company acquired the assets as identified on <U>Schedule 1</U> attached hereto including, without
limitation, the Company Equipment and the Company Intellectual Property (the &ldquo;<B>Acquired Assets</B>&rdquo;), pursuant to an Asset
Purchase Agreement dated as of November 4, 2025 (the &ldquo;<B>Liora Asset Purchase Agreement</B>&rdquo;) entered into among the Company,
Advanced Oncotherapy PLC, a private company incorporated in England which was in &ldquo;Administration&rdquo; and the administrators
named therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company Equipment is located at The Landlord&rsquo;s Daresbury Laboratory Keckwick Ln, Daresbury, Warrington WA4 4AD (the &ldquo;<B>Premises</B>&rdquo;),
pursuant to a lease agreement dated as of November 17, 2025 (the &ldquo;<B>Liora Lease</B>&rdquo;) entered into between the Company and
United Kingdom Research and Innovation, an executive non-departmental public body sponsored by the Department for Science, Innovation
and Technology whose principal office is at Polaris House, North Star Avenue, Swindon SN2 1FL;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Medgenesis Global Inc., a company incorporated and registered in the State of Wyoming (&ldquo;<B>Medgenesis</B>&rdquo;), was the original
owner of 1,000 Ordinary Shares, aggregate nominal value 10GBP per share, of the Company (the &ldquo;<B>Shares</B>&rdquo;), which represented
all of the issued and outstanding equity securities of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
pursuant to a Share Purchase Agreement dated as of November 10, 2025 (the &ldquo;<B>Orbit Purchase Agreement</B>&rdquo;), Medgenesis
sold all of the Shares to Seller free and clear of all Encumbrances;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
as of the date hereof, Seller owns all of the issued and outstanding Shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Seller wishes to sell to PubCo, and PubCo wishes to purchase from Seller, all and not less than all of the Shares, subject to the terms
and conditions set forth herein and in exchange, Seller shall receive certain shares of preferred stock of PubCo and other consideration
as set forth herein (the &ldquo;<B>Share Exchange</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
subject to tax review and analysis, it is the intention of the parties that the Share Exchange shall qualify as a tax-free reorganization
under Section 354 of the Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Share Exchange shall qualify as a transaction in securities exempt from registration or qualification under Section 4(a)(2) of the
Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), Regulation D promulgated thereunder and/or Regulation S
for offers and sales of securities outside the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Definitions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms have the meanings specified or referred to in this <U>ARTICLE I</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Acquisition
Proposal</B>&rdquo; has the meaning set forth in <U>Section 5.03</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Action</B>&rdquo;
means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation,
citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or otherwise, whether at law
or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is
under common control with, such Person. The term &ldquo;control&rdquo; (including the terms &ldquo;controlled by&rdquo; and &ldquo;under
common control with&rdquo;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Agreement</B>&rdquo;
has the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Ancillary
Documents</B>&rdquo; means the Royalty Agreement, the Certificate of Designation, and such other documents and agreements required to
be executed and delivered under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Basket</B>&rdquo;
has the meaning set forth in <U>Section 8.04(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business</B>&rdquo;
means the business of developing and delivering the proton-based radiotherapy solution called LIGHT (Linac Image Guided Hadron Therapy)
as such business is carried on by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means any day except Saturday, Sunday or any other day on which commercial banks located in New York, New York are authorized
or required by Law to be closed for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Cap</B>&rdquo;
has the meaning set forth in <U>Section 8.04(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Certificate
of Designation</B>&rdquo; means the Certificate of Designation of PubCo with respect to the Series C Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing</B>&rdquo;
has the meaning set forth in <U>Section 2.05</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
Date</B>&rdquo; has the meaning set forth in <U>Section 2.05</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
has the meaning set forth in the recitals.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Common Stock</B>&rdquo; has the meaning set forth in <U>Section 3.03(a).</U></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Equipment</B>&rdquo; means the equipment owned by the Company as set forth in <U>Section 3.09</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
Intellectual Property</B>&rdquo; means all Intellectual Property owned by the Company and used in its business as currently conducted.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
IP Agreements</B>&rdquo; means all licenses, sublicenses, consent to use agreements, settlements, coexistence agreements, covenants not
to sue, waivers, releases, permissions and other Contracts, whether written or oral, relating to Intellectual Property to which the Company
is a party, beneficiary or otherwise bound.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
IP Registrations</B>&rdquo; means all Company Intellectual Property that is subject to any issuance, registration or application by or
with any Governmental Authority or authorized private registrar in any jurisdiction, including issued patents, registered trademarks,
domain names and copyrights, and pending applications for any of the foregoing.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Company
IT Systems&rdquo;</B> means all Software, computer hardware, servers, networks, platforms, peripherals, and similar or related items
of automated, computerized, or other information technology (IT) networks and systems (including telecommunications networks and systems
for voice, data and video) owned, leased, licensed, or used (including through cloud-based or other third-party service providers) by
the Company.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Contracts</B>&rdquo;
means all contracts, leases, deeds, mortgages, licenses, instruments, notes, commitments, undertakings, indentures, joint ventures and
all other agreements, commitments and legally binding arrangements, whether written or oral.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Direct
Claim</B>&rdquo; has the meaning set forth in <U>Section 8.05(c)</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Dollars&rdquo;
</B>or <B>&ldquo;$</B>&rdquo; means the lawful currency of the United States.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Drop
Dead Date</B>&rdquo; has the meaning set forth in <U>Section 9.01(b)</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Encumbrance</B>&rdquo;
means any charge, claim, community property interest, pledge, condition, equitable interest, lien (statutory or other), option, security
interest, mortgage, easement, encroachment, right of way, right of first refusal, or restriction of any kind, including any restriction
on use, voting, transfer, receipt of income or exercise of any other attribute of ownership.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchanged
Common Shares</B>&rdquo; means the 2,700,000 shares of PubCo Common Stock initially issuable upon conversion of the Exchanged Preferred
Shares.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchanged
Preferred Shares</B>&rdquo; means the 2,700 shares of Series C Preferred Stock issued to the Seller pursuant to <U>Section 2.02(a)</U>
herein.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchanged
Shares</B>&rdquo; means the Exchanged Preferred Shares and the Exchanged Common Shares.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>GAAP</B>&rdquo;
means United States generally accepted accounting principles in effect from time to time.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Authority</B>&rdquo; means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality
of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental
authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator,
court or tribunal of competent jurisdiction.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
Order</B>&rdquo; means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental
Authority.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnified
Party</B>&rdquo; has the meaning set forth in <U>Section 8.05</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Indemnifying
Party</B>&rdquo; has the meaning set forth in <U>Section 8.05</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Intellectual
Property</B>&rdquo; means any and all rights in, arising out of, or associated with any of the following in any jurisdiction throughout
the world: (a) issued patents and patent applications (whether provisional or non-provisional), including divisionals, continuations,
continuations-in-part, substitutions, reissues, reexaminations, extensions, or restorations of any of the foregoing, and other Governmental
Authority-issued indicia of invention ownership (including certificates of invention, petty patents, and patent utility models) (&ldquo;<B>Patents</B>&rdquo;);
(b) trademarks, service marks, brands, certification marks, logos, trade dress, trade names, and other similar indicia of source or origin,
together with the goodwill connected with the use of and symbolized by, and all registrations, applications for registration, and renewals
of, any of the foregoing (&ldquo;<B>Trademarks</B>&rdquo;); (c) copyrights and works of authorship, whether or not copyrightable, and
all registrations, applications for registration, and renewals of any of the foregoing (&ldquo;<B>Copyrights</B>&rdquo;); (d) internet
domain names and social media account or user names (including &ldquo;handles&rdquo;), whether or not Trademarks, all associated web
addresses, URLs, websites and web pages, social media sites and pages, and all content and data thereon or relating thereto, whether
or not Copyrights; (e) trade secrets, know-how, inventions (whether or not patentable), discoveries, improvements, technology, business
and technical information, databases, data compilations and collections, tools, methods, processes, techniques, and other confidential
and proprietary information and all rights therein (&ldquo;<B>Trade Secrets</B>&rdquo;); (f) computer programs, operating systems, applications,
firmware, and other code, including all source code, object code, application programming interfaces, data files, databases, protocols,
specifications, and other documentation thereof (<B>&ldquo;Software&rdquo;</B>); (g) rights of publicity; and (h) all other intellectual
or industrial property and proprietary rights.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Knowledge
of Seller or Seller&rsquo;s Knowledge</B>&rdquo; or any other similar knowledge qualification, means the actual or constructive knowledge
of any director or officer of Seller or the Company after due inquiry.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Law</B>&rdquo;
means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement
or rule of law of any Governmental Authority.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Liabilities</B>&rdquo;
has the meaning set forth in <U>Section 3.07</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Licensed
Intellectual Property&rdquo;</B> means all Intellectual Property in which the Company holds any rights or interests granted by other
Persons, including Seller or any of its Affiliates.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Losses</B>&rdquo;
means losses, damages, Liabilities, deficiencies, Actions, judgments, interest, awards, penalties, fines, costs or expenses of whatever
kind, including reasonable attorneys&rsquo; fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing
any insurance providers; <I>provided, however,</I> that &ldquo;<B>Losses</B>&rdquo; shall not include punitive damages, except to the
extent actually awarded to a Governmental Authority or other third party.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Material
Adverse Effect</B>&rdquo; means any event, occurrence, fact, condition or change that is, or could reasonably be expected to become,
individually or in the aggregate, materially adverse to (a) the business, results of operations, condition (financial or otherwise) or
assets of the Company or PubCo, as the case may be, or (b) the ability of a party to this Agreement to consummate the transactions contemplated
hereby on a timely basis; <I>provided, however,</I> that &ldquo;Material Adverse Effect&rdquo; shall not include any event, occurrence,
fact, condition or change, directly or indirectly, arising out of or attributable to: (i) general economic or political conditions; (ii)
conditions generally affecting the industries in which the Company or PubCo operates; (iii) any changes in financial or securities markets
in general; (iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof; (v) any
action required or permitted by this Agreement or any action taken (or omitted to be taken) by mutual agreement of the parties hereto;
(vi) any changes in applicable Laws or accounting rules, including GAAP; (vii) the public announcement, pendency or completion of the
transactions contemplated by this Agreement; (viii) any natural or man-made disasters or acts of God; (ix) any epidemics, pandemics,
or disease outbreaks or any worsening thereof; or (x) any failure by the Company or PubCo to meet any internal or published projections,
forecasts or revenue or earnings predictions (provided that the underlying causes of such failures (subject to the other provisions of
this definition) shall not be excluded); <I>provided further, however,</I> that any event, occurrence, fact, condition or change referred
to in clauses (i) through (iv) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred
or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition or change has a disproportionate
effect on the Company or PubCo, as the case may be, compared to other participants in the industries in which the Company or PubCo conducts
its businesses.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permits</B>&rdquo;
means all permits, licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained,
or required to be obtained, from Governmental Authorities.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization,
trust, association or other entity.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PubCo</B>&rdquo;
has the meaning set forth in the preamble.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PubCo
Common Stock</B>&rdquo; means PubCo&rsquo;s common stock, $0.0001 par value per share.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PubCo
Indemnitees</B>&rdquo; has the meaning set forth in <U>Section 8.02</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PubCo
Shareholder Approval</B>&rdquo; means the approval of PubCo&rsquo;s stockholders at a duly convened PubCo Stockholder Meeting.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PubCo
Stockholder Approval Matters</B>&rdquo; means (i) the authorization for the conversion of the Exchanged Preferred Shares into PubCo Common
Stock, and (ii) any other proposals PubCo and Seller mutually agree is necessary or desirable to consummate the transactions contemplated
by this Agreement or in connection with the Share Exchange.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>PubCo
Stockholder Meeting</B>&rdquo; means any annual or special meeting of the stockholders of PubCo.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Real
Property</B>&rdquo; means the real property owned by, or leased or subleased to, the Company, together with all buildings, structures
and facilities located thereon.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Representative</B>&rdquo;
means, with respect to any Person, any and all directors, officers, employees, consultants, financial advisors, counsel, accountants
and other agents of such Person.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller</B>&rdquo;
has the meaning set forth in the preamble.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Seller
Indemnitees</B>&rdquo; has the meaning set forth in <U>Section 8.03</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
C Preferred Stock</B>&rdquo; means the PubCo&rsquo;s Series C Preferred Stock having the rights and preferences as set forth in the Certificate
of Designation attached hereto as <U>Exhibit 1</U>, which Series C Preferred Stock shall have a face value of $1,000 per share, shall
be non-voting and shall be convertible into the Exchanged Common Shares.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shares</B>&rdquo;
has the meaning set forth in the recitals.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Taxes</B>&rdquo;
means all federal, state, local, foreign and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise, registration,
profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental,
stamp, occupation, premium, property (real or personal), real property gains, windfall profits, customs, duties or other taxes, fees,
assessments or charges of any kind whatsoever, together with any interest, additions or penalties with respect thereto and any interest
in respect of such additions or penalties.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Tax
Return</B>&rdquo; means any return, declaration, report, claim for refund, information return or statement or other document relating
to Taxes, including any schedule or attachment thereto, and including any amendment thereof.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Third-Party
Claim</B>&rdquo; has the meaning set forth in <U>Section 8.05(a)</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trade
Secrets</B>&rdquo; has the meaning set forth in the definition of Intellectual Property.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trademarks</B>&rdquo;
has the meaning set forth in the definition of Intellectual Property.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SHARE
EXCHANGE</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
2.01 Exchange.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the terms and conditions
set forth herein, and in reliance upon the representations, warranties, and covenants contained in this Agreement, at the Closing, each
Seller shall sell, transfer and assign to PubCo, and PubCo shall acquire from Seller, all of the Shares, free and clear of all Encumbrances,
in exchange for the consideration specified in <U>Section 2.02</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.02 <FONT STYLE="color: black; vertical-align: baseline">Consideration; PubCo Shares.</FONT></B> In exchange for PubCo&rsquo;s purchase
of the Shares from Seller, PubCo shall pay the following consideration to Seller at the Closing:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
PubCo shall issue to Seller the Exchanged Preferred Shares consisting of 2,700 shares of PubCo&rsquo;s Series C Preferred Stock;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Pay to Seller 10.56 Bitcoin and 300 Ethereum (collectively, the &ldquo;<B>Digital Payment</B>&rdquo;);</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Pay $440,000 in cash to Seller, and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Execute and deliver a royalty agreement to Seller in the form attached hereto as <U>Exhibit 2</U> (the &ldquo;<B>Royalty Agreement</B>&rdquo;),
pursuant to which PubCo will pay the Seller a royalty (the &ldquo;<B>Royalty</B>&rdquo;) equal to 10% of the net revenues derived from
(i) the operation or use of the Company Equipment, (ii) the licensing of the Company Equipment to any third-parties, and (iii) any consideration
received from the sale or other monetization or commercialization of the Company Equipment; provided, however that the maximum Royalty
payable by PubCo (or any successor in interest) to Seller hereunder shall not exceed $45,000,000.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
2.03 Transactions to be Effected at the Closing.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At the Closing, PubCo shall:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
deliver to Seller certificates representing the Exchanged Preferred Shares or proof of book-entry transfer of such Exchanged Preferred
Shares registered in the name of Seller;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
pay to Seller the amount of $440,000 by wire transfer of immediately available funds to an account specified by Seller within three Business
Days after the Closing;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
pay to Seller the Digital Payments to one or more digital accounts specified by Seller within three Business Days after to the Closing;
and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
deliver to the Seller, duly executed Ancillary Documents to which PubCo is a party, and all other agreements, documents, instruments
or certificates required to be delivered by PubCo at or prior to the Closing pursuant to <U>Section 7.03</U> of this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At the Closing, Seller shall deliver to PubCo:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
stock certificates evidencing the Shares, free and clear of all Encumbrances, duly endorsed in blank or accompanied by stock powers or
other instruments of transfer duly executed in blank, with all required stock transfer tax stamps affixed thereto; and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
duly executed Ancillary Documents to which Seller is party to, as applicable, and all other agreements, documents, instruments or certificates
required to be delivered by Seller at or prior to the Closing pursuant to <U>Section 7.02</U> of this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.04 <FONT STYLE="color: black; vertical-align: baseline">Closing.</FONT></B> Subject to the terms and conditions of this Agreement,
the Share Exchange contemplated hereby shall take place at a closing (the &ldquo;<B>Closing</B>&rdquo;) to be held at 10:00 a.m., New
York time, no later than two Business Days after the last of the conditions to Closing set forth in <U>ARTICLE VII</U> have been satisfied
or waived (other than conditions which, by their nature, are to be satisfied on the Closing Date), remotely by electronic exchange of
documents and signatures, or at such other time or on such other date or at such other place as Seller and PubCo may mutually agree upon
in writing (the day on which the Closing takes place being the &ldquo;<B>Closing Date</B>&rdquo;).</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III<FONT STYLE="text-transform: uppercase"><BR>
Representations and warranties of seller</FONT></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the correspondingly numbered Section of the disclosure schedules delivered by Seller (the &ldquo;<B>Seller&rsquo;s Disclosure
Letter</B>&rdquo;) on or after the date hereof, it being specifically agreed that disclosure of any item in any section of the Seller&rsquo;s
Disclosure Letter (whether or not an explicit cross reference appears) shall be deemed to be a disclosure with respect to any other section
to which the relevance of such item is reasonably apparent, Seller hereby represents and warrants to PubCo that, as of the date hereof:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.01 Organization and Authority of Seller.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller
has full power and authority to enter into this Agreement and the Ancillary Documents to which Seller is or will be a party, to carry
out its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery
by Seller of this Agreement and the Ancillary Document to which Seller is or will be a party, the performance by Seller of its obligations
hereunder and thereunder, and the consummation by Seller of the transactions contemplated hereby and thereby have been duly authorized
by all requisite corporate or other action that is or may be required on the part of Seller. This Agreement has been duly executed and
delivered by Seller, and (assuming due authorization, execution and delivery by PubCo) this Agreement constitutes a legal, valid and
binding obligation of Seller enforceable against Seller in accordance with its terms. When each other Ancillary Document to which Seller
is or will be a party has been duly executed and delivered by Seller (assuming due authorization, execution and delivery by each other
party thereto), such Ancillary Document will constitute a legal and binding obligation of Seller enforceable against it in accordance
with its terms.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.02 Organization, Authority and Qualification of the Company.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a corporation duly organized, validly existing and in good standing under the Laws of England and Wales. The Company has full
corporate power and authority to own, operate or lease the properties and assets now owned, operated or leased by it and to carry on
its business as it has been and is currently conducted. The Company is duly licensed or qualified to do business and is in good standing
in each jurisdiction in which the properties owned or leased by it or the operation of its business as currently conducted makes such
licensing or qualification necessary, except where the failure to be so qualified or in good standing would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effective on the Company. All corporate actions taken by the Company in
connection with this Agreement and the Ancillary Documents to which the Company is a party, has been duly authorized.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.03 Capitalization; Ownership of Shares.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As of the date of this Agreement, the authorized capital stock of the Company consists of 1,000 Ordinary Shares, nominal value GBP0.01
per share (&ldquo;<B>Company Common Stock</B>&rdquo;), of which 1,000 shares are issued and outstanding and constitute the Shares. All
of the Shares have been duly authorized, are validly issued, fully paid and non-assessable, and are owned of record and beneficially
by the Seller, free and clear of all Encumbrances. Upon consummation of the transactions contemplated by this Agreement, PubCo will be
the record and beneficial owner of all of the Shares, free and clear of all Encumbrances.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
None of the Shares were issued in violation of any agreement, arrangement or commitment to which Seller or the Company is a party or
is subject to or in violation of any preemptive or similar rights of any Person.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.04 No other Subsidiaries or Business.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the
date of this Agreement, the Company&rsquo;s sole business and operations is the ownership of the Acquired Assets. The Company does not
own or operate any other subsidiaries and does not own any equity interest in any other entity.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.05 No Conflicts; Consents.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The execution, delivery
and performance by Seller of this Agreement and the Ancillary Documents to which it is or will be a party, and the consummation of the
transactions contemplated hereby and thereby, do not and will not: (a) conflict with or result in a material violation or breach of,
or default under, any provision of the certificate of incorporation, by-laws or other organizational documents of Seller or the Company;
(b) conflict with or result in a material violation or breach of any provision of any Law or Governmental Order applicable to Seller
or the Company; (c) require the consent, notice or other action by any Person under, conflict with, result in a material violation or
breach of, constitute a default or an event that, with or without notice or lapse of time or both, would constitute a default under,
result in the acceleration of or create in any party the right to accelerate, terminate, modify or cancel any Contract to which any Seller
or the Company is a party or by which Seller or the Company is bound or to which any of their respective properties and assets are subject,
or any Permit affecting the properties, assets or business of the Company; or (d) result in the creation or imposition of any Encumbrance
other than Permitted Encumbrances on any properties or assets of the Company. No consent, approval, Permit, Governmental Order, declaration
or filing with, or notice to, any Governmental Authority is required by or with respect to Seller or the Company in connection with the
execution and delivery of this Agreement and the Ancillary Documents to which Seller or the Company is or will be a party and the consummation
of the transactions contemplated hereby and thereby.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.06 [Reserved]</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.07 <FONT STYLE="color: black; vertical-align: baseline">Undisclosed Liabilities.</FONT></B> The Company does not have any liabilities,
obligations or commitments of any nature whatsoever, whether absolute or contingent, accrued or unaccrued, matured or unmatured or otherwise
(&ldquo;<B>Liabilities</B>&rdquo;), other than (a) those set forth in <U>Schedule 3.07 of the Seller&rsquo;s Disclosure Schedules</U>,
(b) those which are adequately reflected or reserved against in the Balance Sheet as of the Balance Sheet Date, and (c) those which have
been incurred in the ordinary course of business consistent with past practice since the Balance Sheet Date and which are not, individually
or in the aggregate, material in amount.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.08 <FONT STYLE="color: black; vertical-align: baseline">[Reserved] </FONT></B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.09 Company Equipment. </B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has good and
valid title to all of the Acquired Assets including the machinery and equipment set forth on <U>Schedule 3.09 of the Seller&rsquo;s Disclosure
Schedules</U> (the &ldquo;<U>Company Equipment</U>&rdquo;), and any Intellectual Property related thereto, free and clear of all Encumbrances.
The Company Equipment is all of the equipment needed by the Company to operate its business as currently conducted.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.10 <FONT STYLE="color: black; vertical-align: baseline">Title to Other Assets; Real Property.</FONT></B> The Company has good and valid
title to, or a valid leasehold interest in, all Real Property (including the Liora Lease) and personal property and other assets used
in the operation of its. The Company does not own or lease any Real Property other than pursuant to the Liora Lease. A true and correct
copy of the Liora Lease has been provided by Seller to PubCo.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.11 Condition and Sufficiency of Assets.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fixtures,
machinery, equipment, and other items of tangible personal property currently owned or leased by the Company including, without limitation,
the Company Equipment, are structurally sound, are in good operating condition and repair, and are adequate for the uses to which they
are being put, and none of such fixtures, machinery, equipment, and other items of tangible personal property is in need of maintenance
or repairs except for ordinary, routine maintenance and repairs that are not material in nature or cost. The fixtures, machinery, equipment,
and other items of tangible personal property currently owned or leased by the Company, together with all other properties and assets
of the Company, are sufficient for the continued conduct of the Company&rsquo;s Business after the Closing in substantially the same
manner as conducted prior to the Closing and constitute all of the rights, property and assets necessary to conduct the Business of the
Company.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.12 Intellectual Property.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Section 3.12(a) of the Seller&rsquo;s Disclosure Schedules</U> contains a correct, current, and complete list of: (i) all Company
IP Registrations, specifying as to each, as applicable: the title, mark, or design; the record owner and inventor(s), if any; the jurisdiction
by or in which it has been issued, registered, or filed; the patent, registration, or application serial number; the issue, registration,
or filing date; and the current status; and (ii) all unregistered Trademarks included in the Company Intellectual Property; and (iii)
all proprietary Software of the Company; and (iv) all other Company Intellectual Property used or held for use in the Company&rsquo;s
business as currently conducted and as proposed to be conducted.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Section 3.12(b) of the Disclosure Schedules</U> contains a correct, current, and complete list of all Company IP Agreements, specifying
for each the date, title, and parties thereto, and separately identifying the Company IP Agreements: (i) under which Company is a licensor
or otherwise grants to any Person any right or interest relating to any Company Intellectual Property; (ii) under which Company is a
licensee or otherwise granted any right or interest relating to the Intellectual Property of any Person; and (iii) which otherwise relate
to Company&rsquo;s ownership or use of Intellectual Property. The Company has provided PubCo with true and complete copies (or in the
case of any oral agreements, a complete and correct written description) of all Company IP Agreements, including all modifications, amendments
and supplements thereto and waivers thereunder. Each Company IP Agreement is valid and binding on the Company in accordance with its
terms and is in full force and effect. Neither the Company nor any other party thereto is, or is alleged to be, in breach of or default
under, or has provided or received any notice of breach of, default under, or intention to terminate (including by non-renewal), any
Company IP Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as set forth in <U>Section 3.12(c) of the Disclosure Schedules</U>, the Company is the sole and exclusive legal and beneficial,
and with respect to the Company IP Registrations, record, owner of all right, title, and interest in and to the Company Intellectual
Property, and has the valid and enforceable right to use all other Intellectual Property used or held for use in or necessary for the
conduct of the Company&rsquo;s business as currently conducted and as proposed to be conducted, in each case, free and clear of Encumbrances.
The Company has entered into binding, valid and enforceable, written Contracts with each current and former employee and independent
contractor who is or was involved in or has contributed to the invention, creation, or development of any Intellectual Property during
the course of employment or engagement with the Company whereby such employee or independent contractor (i) acknowledges the Company&rsquo;s
exclusive ownership of all Intellectual Property invented, created, or developed by such employee or independent contractor within the
scope of his or her employment or engagement with the Company; (ii) grants to the Company a present, irrevocable assignment of any ownership
interest such employee or independent contractor may have in or to such Intellectual Property, to the extent such Intellectual Property
does not constitute a &ldquo;work made for hire&rdquo; under applicable Law; and (iii) irrevocably waives any right or interest, including
any moral rights, regarding any such Intellectual Property, to the extent permitted by applicable Law. The Company has provided PubCo
with true and complete copies of all such Contracts. All assignments and other instruments necessary to establish, record, and perfect
the Company&rsquo;s ownership interest in the Company IP Registrations have been validly executed, delivered, and filed with the relevant
Governmental Authorities and authorized registrars.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Neither the execution, delivery or performance of this Agreement, nor the consummation of the transactions contemplated hereunder, will
result in the loss or impairment of, or require the consent of any other Person in respect of, the Company&rsquo;s right to own or use
any Company Intellectual Property or Licensed Intellectual Property.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
All of the Company Intellectual Property and Licensed Intellectual Property are valid and enforceable, and all Company IP Registrations
are subsisting and in full force and effect. The Company has taken all reasonable and necessary steps to maintain and enforce the Company
Intellectual Property and Licensed Intellectual Property and to preserve the confidentiality of all Trade Secrets included in the Company
Intellectual Property, including by requiring all Persons having access thereto to execute binding, written non-disclosure agreements.
All required filings and fees related to the Company IP Registrations have been timely submitted with and paid to the relevant Governmental
Authorities and authorized registrars. The Company has provided PubCo with true and complete copies of all file histories, documents,
certificates, office actions, correspondence, assignments, and other instruments relating to the Company IP Registrations.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The conduct of Company the Company&rsquo;s business as currently and formerly conducted, including the use of the Company Intellectual
Property and Licensed Intellectual Property in connection therewith, and the products, processes and services of the Company have not
infringed, misappropriated or otherwise violated, and will not infringe, misappropriate or otherwise violate, the Intellectual Property
or other rights of any Person. No Person has infringed, misappropriated or otherwise violated any Company Intellectual Property or Licensed
Intellectual Property.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
There are no Actions (including any opposition, cancellation, revocation, review, or other proceeding), whether settled, pending, or
threatened (including in the form of offers to obtain a license): (i) alleging any infringement, misappropriation, or other violation
by the Company of the Intellectual Property of any Person; (ii) challenging the validity, enforceability, registrability, patentability,
or ownership of any Company Intellectual Property or Licensed Intellectual Property or the Company&rsquo;s right, title, or interest
in or to any Company Intellectual Property or Licensed Intellectual Property; or (iii) by the Company or by the owner of any Licensed
Intellectual Property alleging any infringement, misappropriation, or other violation by any Person of the Company Intellectual Property
or such Licensed Intellectual Property. Neither Seller nor the Company is aware of any facts or circumstances that could reasonably be
expected to give rise to any such Action. The Company is not subject to any outstanding or prospective Governmental Order (including
any motion or petition therefor) that does or could reasonably be expected to restrict or impair the use of any Company Intellectual
Property or Licensed Intellectual Property.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Section 3.12(h) of the Disclosure Schedules</U> contains a correct, current, and complete list of all social media accounts used in
the Company&rsquo;s business. The Company has complied with all terms of use, terms of service, and other Contracts and all associated
policies and guidelines relating to its use of any social media platforms, sites, or services (collectively, &ldquo;<B>Platform Agreements</B>&rdquo;).
There are no Actions, whether settled, pending, or threatened, alleging any (i) breach or other violation of any Platform Agreement by
the Company; or (ii) defamation, violation of publicity rights of any Person, or any other violation by the Company in connection with
its use of social media.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
All Company IT Systems are in good working condition and are sufficient for the operation of the Company&rsquo;s business as currently
conducted. In the past three years, there has been no malfunction, failure, continued substandard performance, denial-of-service, or
other cyber incident, including any cyberattack, or other impairment of the Company IT Systems that has resulted or is reasonably likely
to result in disruption or damage to the business of the Company. The Company has taken all commercially reasonable steps to safeguard
the confidentiality, availability, security, and integrity of the Company IT Systems, including implementing and maintaining appropriate
backup, disaster recovery, and Software and hardware support arrangements.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company has complied with all applicable Laws and all publicly posted policies, notices, and statements concerning the collection,
use, processing, storage, transfer, and security of personal information in the conduct of the Company&rsquo;s business. In the past
three years, the Company has not (i) experienced any actual, alleged, or suspected data breach or other security incident involving personal
information in its possession or control or (ii) been subject to or received any written notice of any audit, investigation, complaint,
or other Action by any Governmental Authority or other Person concerning the Company&rsquo;s collection, use, processing, storage, transfer,
or protection of personal information or actual, alleged, or suspected violation of any applicable Law concerning privacy, data security,
or data breach notification, and to Seller&rsquo;s Knowledge, there are no facts or circumstances that could reasonably be expected to
give rise to any such Action.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.13 Legal Proceedings; Governmental Orders.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
There are no Actions pending or, to Seller&rsquo;s Knowledge, threatened (a) against or by the Company, which has a Material Adverse
Effect on the Company or any of its properties or assets (or by or against Seller or any Affiliate thereof and relating to the Company);
or (b) against or by Seller or any Affiliate of Seller (including the Company) that challenges or seeks to prevent, enjoin or otherwise
delay the transactions contemplated by this Agreement. No event has occurred, or circumstances exist that may give rise to, or serve
as a basis for, any such Action.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
There are no outstanding Governmental Orders and no unsatisfied judgments, penalties or awards against or affecting the Company or any
of its properties or assets.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.14 Compliance With Laws; Permits.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company has complied, and is now complying, in all material respects with all Laws applicable to its business, properties or assets.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All material Permits required for the Company to conduct its business have been obtained by it and are valid and in full force and effect.
All fees and charges with respect to such Permits as of the date hereof have been paid in full.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.15 Taxes.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All Tax Returns required to be filed on or before the Closing Date by the Company have been, or will be, timely filed. Such Tax Returns
are, or will be, true, complete and correct in all material respects. All Taxes due and owing by the Company (whether or not shown on
any Tax Return) have been, or will be, timely paid.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company has withheld and paid each Tax required to have been withheld and paid in connection with amounts paid or owing to any employee,
independent contractor, creditor, customer, shareholder or other party, and complied with all information reporting and backup withholding
provisions of applicable Law in all material respect.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No claim has been made by any taxing authority against the Company in any jurisdiction where the Company may be subject to Tax by that
jurisdiction.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
There are no pending, or to Seller&rsquo;s Knowledge, threatened, Actions by any taxing authority against the Company.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Seller or the Company has delivered to PubCo copies of all federal, state, local and foreign income, franchise and similar Tax Returns,
examination reports, and statements of deficiencies assessed against, or agreed to by, the Company for all Tax periods ending after 2020.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company is not a party to, or bound by, any Tax indemnity, Tax sharing or Tax allocation agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Section 3.15(g) of the Seller&rsquo;s Disclosure Schedules</U> sets forth all foreign jurisdictions in which the Company is subject
to Tax, is engaged in business or has a permanent establishment.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.16 Material Contracts.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; color: black; vertical-align: baseline">(a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth in <U>Schedule 3.16(a) of the Seller&rsquo;s
Disclosure Letter</U>, <FONT STYLE="font-weight: normal; color: black; vertical-align: baseline">as of the date of this Agreement, the
Company</FONT> is not a party to any of the following contracts that are currently in effect (each being a &ldquo;<B>Material Contracts</B>&rdquo;):</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Contracts involving aggregate consideration payable by the Company in excess of $25,000 and which, in each case, cannot be cancelled
by the Company without penalty or without more than 90 days&rsquo; notice;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Contracts that require royalty or other payments to use any material Company Intellectual Property;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Contracts that require the Company to purchase its total requirements of any product or service from a third party or that contain &ldquo;take
or pay&rdquo; provisions;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Contracts that provide for the assumption by the Company of any Tax, environmental or other Liability of any Person;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
Contracts that relate to the acquisition or disposition of any business, a material amount of stock or assets of any other Person or
any material real property (whether by merger, sale of stock, sale of assets or otherwise) that is not in the ordinary course of business
of the Company;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Contracts relating to Indebtedness (including, without limitation, guarantees) of the Company in excess of $25,000;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
Contracts that limit or purport to limit the ability of the Company to compete in any line of business or with any Person or in any geographic
area that the Company currently conducts business in or competes in;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
Contracts to which the Company is a party that provides for any joint venture, partnership or similar arrangement by the Company with
any other Person; and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
Collective bargaining agreements or Contracts with any union to which the Company is a party or any employment, consulting or similar
agreement that is not terminable at will by the Company with no more than 30 days notice and without any ongoing obligation or severance
or other similar obligation.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Agreement, each Material Contract set forth in <U>Schedule 3.14(b)</U> of the Seller&rsquo;s Disclosure Letter is
in full force and effect and is a valid and binding agreement enforceable against AMPX and, to Seller&rsquo;s Knowledge, the other party
or parties thereto, in accordance with its terms.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.17 Books and Records.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The minute books and stock
record books of the Company, all of which have been made available to PubCo, are complete and correct and have been maintained in accordance
with sound business practices. The minute books of the Company contain accurate and complete records of all meetings, and actions taken
by written consent of, the stockholders, the board of directors and any committees of the board of directors of the Company, and no meeting,
or action taken by written consent, of any such stockholders, board of directors or committee has been held for which minutes have not
been prepared and are not contained in such minute books. At the Closing, all of those books and records will be in the possession of
the Company.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.18 Related Party Transactions.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth
on <U>Section 3.18 of the Seller&rsquo;s Disclosure Schedules</U>, there are no Contracts or other arrangements involving the Company
in which any Seller, its Affiliates, or any of its or their respective directors, officers, or employees or any immediate family members
thereof is a party, has a financial interest, or otherwise owns or leases any material asset, property, or right which is used by the
Company.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
3.19 Brokers.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as set forth in the <U>Section
3.19 of the Seller&rsquo;s Disclosure Letter</U>, no broker, finder or investment banker (collectively, a &ldquo;<B>Broker</B>&rdquo;)
is entitled to any brokerage, finder&rsquo;s or other fee or commission in connection with the transactions contemplated by this Agreement
based upon arrangements made by or on behalf of the any Seller.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
3.20 Investment Representations. </B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Seller has been given access PubCo&rsquo;s filings with the United States Securities and Exchange Commission available at www.sec.gov
(&ldquo;<B>SEC Filings</B>&rdquo;) and has utilized such access for the purpose of obtaining investment information about PubCo.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Seller acknowledges that an investment in the Exchanged Shares involves a high degree of risk and each Seller has read and understands
the SEC Filings, including the risk factors included in PubCo&rsquo;s most recent Annual Report on Form 10-K and subsequent quarterly
reports on Form 10-Q. Seller is in a financial position to hold the Exchanged Shares indefinitely and is able to bear the economic risk
and withstand a complete loss of an investment in the Exchanged Shares.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Seller has obtained, to the extent Seller deems necessary, professional advice with respect to the risks inherent in the investment in
the Exchanged Shares, the condition and business of PubCo, and the suitability of the investment in the Exchanged Shares in light of
Seller&rsquo;s financial condition and investment objectives.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Seller, either alone or with the assistance of such Seller&rsquo;s professional advisor(s), if any, is a sophisticated investor, is able
to fend for itself in the transactions contemplated by this Agreement, and has such knowledge and experience in financial and business
matters that Seller is capable of evaluating the merits and risks of the prospective investment in the PubCo Common Stock.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Exchanged Shares will be acquired for investment purposes for Seller&rsquo;s own account, not as a nominee or agent, and not with
a view to the distribution of any part thereof. Seller has no present intention of selling, granting any participation in or otherwise
distributing the same in a manner contrary to the Act, or any applicable state securities or blue sky law, and Seller does not have any
contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation to such person or to any third
person, with respect to any of the Exchanged Shares.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Seller has been solely responsible for Seller&rsquo;s own due diligence investigation of PubCo and its business, and Seller&rsquo;s analysis
of the merits and risks of the investment made pursuant to this Agreement, and is not relying on anyone else&rsquo;s analysis or investigation
of PubCo, its business or the merits and risks of the Exchanged Shares, other than professionals employed or engaged specifically by
Seller to assist Seller in taking any action or performing any role relative to the arranging of the investments being made pursuant
to this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Seller acknowledges and understands that the issuance of the Exchanged Shares has not been, and will not be, registered under the Act
or under the securities laws of any state or other jurisdiction, and the Exchanged Shares are characterized under the Securities Act
as a &ldquo;restricted security&rdquo; and therefore, cannot be sold or transferred unless such resale is subsequently registered under
the Securities Act or an exemption from such registration is available. Seller represents that Seller is familiar with Rule 144 promulgated
under the Securities Act (&ldquo;<B>Rule 144</B>&rdquo;), as presently in effect, and understands the resale limitations imposed thereby
and by the Securities Act.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Seller has been advised that the issuance of the Exchanged Shares is not being registered under the Securities Act or any other applicable
securities laws of any country or state, and is being offered and sold pursuant to exemptions from such laws, and that PubCo&rsquo;s
reliance upon such exemptions is predicated in part on Seller&rsquo;s representations contained herein. Seller represents that it is
either (1) not a United States of America citizen or resident of any state therein or (2) is an &ldquo;accredited investor&rdquo; as
defined under Rule 501(a) of Regulation D under the Securities Act, that it has not been organized for the specific purpose of investing
in the Exchange Shares and is not acquiring the Exchanged Shares as the result of any &ldquo;general solicitation&rdquo; or &ldquo;general
advertising&rdquo; as those terms are used in Regulation D under the Securities Act.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Seller acknowledges and understands that the conversion of Exchanged Preferred Shares is limited until receipt of the PubCo Shareholder
Approval.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Without in any way limiting the representations set forth above, Seller further agrees that he, she or it may not make any disposition
of all or any portion of the Exchanged Shares unless and until:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is
made in accordance with such registration statement;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Seller shall have notified PubCo of the proposed disposition and shall have furnished PubCo with a detailed statement of the circumstances
surrounding the proposed disposition, and Seller shall have furnished PubCo with an opinion of counsel, reasonably satisfactory to PubCo,
that such disposition will not require registration of such shares under Securities the Act; or</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
such proposed disposition complies in all respects with Rule 144 or any successor rule or Regulation S providing a safe harbor for such
dispositions without registration and Seller shall have furnished PubCo with an opinion of counsel, reasonably satisfactory to PubCo,
that such disposition is in accordance with Rule 144 or Regulation S.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Representations
and warranties of PubCo</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in the correspondingly numbered section of the disclosure schedules delivered by PubCo (the &ldquo;<B>PubCo Disclosure Letter</B>&rdquo;)
on or after the date hereof, it being agreed that disclosure of any item in any section of the PubCo Disclosure Letter (whether or not
an explicit cross reference appears) shall be deemed to be a disclosure with respect to any other section to which the relevance of such
item is reasonably apparent, PubCo represents and warrants to Seller that the statements contained in this <U>Article IV</U> are true
and correct as of the date hereof.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
4.01 Organization and Authority of PubCo.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PubCo is
a corporation duly organized, validly existing and in good standing under the Laws of the state of Delaware. PubCo has full corporate
power and authority to enter into this Agreement and the Ancillary Documents to which PubCo is or will be a party, to carry out its obligations
hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery by PubCo of this
Agreement and any Ancillary Document to which PubCo is or will be a party, the performance by PubCo of its obligations hereunder and
thereunder and the consummation by PubCo of the transactions contemplated hereby and thereby have been duly authorized by all requisite
corporate action on the part of PubCo. This Agreement has been duly executed and delivered by PubCo, and (assuming due authorization,
execution and delivery by Seller) this Agreement constitutes a legal, valid and binding obligation of PubCo enforceable against PubCo
in accordance with its terms. When each Ancillary Document to which PubCo is or will be a party has been duly executed and delivered
by PubCo (assuming due authorization, execution and delivery by each other party thereto), such Ancillary Document will constitute a
legal and binding obligation of PubCo enforceable against it in accordance with its terms.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
4.02 No Conflicts; Consents.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The execution, delivery
and performance by PubCo of this Agreement and the Ancillary Documents to which it is or will be a party, and the consummation of the
transactions contemplated hereby and thereby, do not and will not: (a) conflict with or result in a violation or breach of, or default
under, any provision of the certificate of incorporation, by-laws or other organizational documents of PubCo subject to the filing of
the Series H Designation with the State of Delaware; (b) conflict with or result in a violation or breach of any provision of any Law
or Governmental Order applicable to PubCo; or (c) except as set forth in <U>Section 4.02 of the PubCo Disclosure Letter</U>, require
the consent, notice or other action by any Person under any Contract to which PubCo is a party. No consent, approval, Permit, Governmental
Order, declaration or filing with, or notice to, any Governmental Authority is required by or with respect to PubCo in connection with
the execution and delivery of this Agreement and the Ancillary Documents to which PubCo is or will be a party and the consummation of
the transactions contemplated hereby and thereby, except for such consents, approvals, Permits, Governmental Orders, declarations, filings
or notices which, in the aggregate, would not have a material adverse effect on the ability of PubCo to consummate the transactions contemplated
hereby on a timely basis.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
4.03 Investment Purpose.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PubCo is acquiring the Shares
solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution
thereof. PubCo acknowledges that the Shares are not registered under the Securities Act, or any state securities laws, and that the Shares
may not be transferred or sold except pursuant to the registration provisions of the Securities Act or pursuant to an applicable exemption
therefrom and subject to state securities laws and regulations, as applicable.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
4.04 Brokers.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No broker, finder or investment banker
is entitled to any brokerage, finder&rsquo;s or other fee or commission in connection with the transactions contemplated by this Agreement
or based upon arrangements made by or on behalf of PubCo.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.05 Capital Stock.</B>
The authorized capital stock of PubCo consists of 100,000,000 shares of PubCo Common Stock and 10,000,000 shares of PubCo Preferred Stock
(the &ldquo;<B>Preferred Stock</B>&rdquo;). As of the close of business on November 19, 2025 (the &ldquo;<B>Measurement Date</B>&rdquo;),
(i) 6,270,540 shares of PubCo Common Stock (excluding treasury shares) are issued and outstanding, all of which were validly issued,
fully paid and nonassessable (which term means that no further sums are required to be paid by the holders thereof in connection with
the issue of such shares) and are free of preemptive rights, (ii) 3,573,130 shares of Series B Preferred Stock are issued and outstanding
which are convertible into 3,573,130 shares of PubCo Common Stock, (iii) 3,500,000 shares of PubCo Common Stock are reserved for issuance
under stock options or other incentive rights granted by PubCo, (iv) 6,539,465 shares of PubCo Common Stock are reserved for issuance
under warrants issued by the PubC, (v) 2,700 shares of Series C Preferred Stock are authorized and reserved for issuance pursuant to
this Agreement (upon the filing of the Series C Designation) and (vi) 2,700,000 shares of PubCo Common Stock are reserved for issuance
upon conversion of the Series C Preferred Stock. Except as listed above, PubCo does not have any outstanding warrants, bonds, debentures,
notes or other obligations (or those that are convertible into, or exchangeable or exercisable for, PubCo Common Stock). Except as set
forth above or in <U>Section 4.05 of the PubCo Disclosure Letter</U>, there are no outstanding (A) shares of capital stock or other voting
securities or equity interests of PubCo or any of its Subsidiaries, (B) securities of PubCo or any of its Subsidiaries convertible into
or exchangeable or exercisable for shares of capital stock of PubCo or any of its Subsidiaries or other voting securities or equity interests
of PubCo or any of its Subsidiaries, (C) stock appreciation rights, &ldquo;phantom&rdquo; stock rights, performance units, interests
in or rights to the ownership or earnings of PubCo or any of its Subsidiaries or other equity equivalent or equity-based awards or rights,
(D) subscriptions, options, warrants, calls, commitments, Contracts or other rights to acquire from PubCo or any of its Subsidiaries,
or obligations of PubCo or any of its Subsidiaries to issue, any shares of capital stock of PubCo or any of its Subsidiaries, voting
securities, equity interests or securities convertible into or exchangeable or exercisable for capital stock or other voting securities
or equity interests of PubCo or any of its Subsidiaries or rights or interests described in the preceding clause (C), or (E) obligations
of PubCo or any of its Subsidiaries to repurchase, redeem or otherwise acquire any such securities or to issue, grant, deliver or sell,
or cause to be issued, granted, delivered or sold, any such securities. There are no stockholder agreements, voting trusts or other agreements
or understandings to which PubCo or any of its Subsidiaries is a party or of which PubCo has knowledge with respect to the holding, voting,
registration, redemption, repurchase or disposition of, or that restricts the transfer of, any capital stock or other voting securities
or equity interests of PubCo or any of its Subsidiaries. Except as set forth in <U>Schedule 4.05 of the PubCo Disclosure Letter</U>,
the execution and performance of this Agreement and the Share Exchange contemplated herein, the issuance of the Exchanged Common Shares
and the Exchanged Preferred Shares will not violate or conflict with the terms and conditions of any warrants issued by the PubCo and
will not trigger any changes, amendments, or adjustments, including without limitation, any price adjustment, reset, anti-dilution or
similar adjustment.<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.06 SEC Reporting. </B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
PubCo has filed with or furnished to the SEC on a timely basis true and complete copies of all forms, reports, schedules, statements
and other documents required to be filed with or furnished to the SEC by PubCo since January 1, 2023, including all SEC Filings (all
such documents, together with all exhibits and schedules to the foregoing materials and all information incorporated therein by reference,
the &ldquo;<U>PubCo SEC Documents</U>&rdquo;). As of their respective filing dates (or, if amended or superseded by a filing prior to
the date of this Agreement, then on the date of such filing), the PubCo SEC Documents complied in all material respects with the applicable
requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act of 2002 (the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;),
as the case may be, including, in each case, the rules and regulations promulgated thereunder, and none of the PubCo SEC Documents contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The financial statements (including the related notes and schedules thereto) included (or incorporated by reference) in the PubCo SEC
Documents (i) have been prepared in a manner consistent with the books and records of PubCo, (ii) have been prepared in accordance with
GAAP (except, in the case of unaudited statements, as permitted by Form 10-Q of the SEC) applied on a consistent basis during the periods
involved (except as may be indicated in the notes thereto), (iii) comply as to form in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC with respect thereto and (iv) fairly present in all material respects
the consolidated financial position of PubCo and its consolidated subsidiaries as of the dates thereof and their respective consolidated
results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal and recurring
year-end audit adjustments that were not, or are not expected to be, material in amount), all in accordance with GAAP and the applicable
rules and regulations promulgated by the SEC. Since January 1, 2023, PubCo has not made any change in the accounting practices or policies
applied in the preparation of its financial statements, except as required by GAAP, SEC rule or policy or applicable Law. The books and
records of PubCo have been, and are being, maintained in all material respects in accordance with GAAP (to the extent applicable) and
any other applicable legal and accounting requirements and reflect only actual transactions.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
PubCo maintains and since January 1, 2023, has maintained disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under
the Exchange Act. Such disclosure controls and procedures are reasonably designed and reasonably effective to ensure that all information
(both financial and non-financial) relating to PubCo and its Subsidiaries required to be disclosed in PubCo&rsquo;s periodic reports
under the Exchange Act is made known to PubCo&rsquo;s principal executive officer and its principal financial officer by others within
PubCo or any of its Subsidiaries, and such disclosure controls and procedures are effective in timely alerting PubCo&rsquo;s principal
executive officer and its principal financial officer to such information required to be included in PubCo&rsquo;s periodic reports required
under the Exchange Act. PubCo maintains a system of &ldquo;internal control over financial reporting&rdquo; (as defined in Rules 13a-15(f)
and 15d-15(f) under the Exchange Act) reasonably sufficient (i) to provide reasonable assurance (A) that transactions are recorded as
necessary to permit preparation of financial statements in conformity with GAAP consistently applied, (B) that transactions are executed
only in accordance with the authorization of management, and (C) regarding prevention or timely detection of the unauthorized acquisition,
use or disposition of PubCo&rsquo;s properties or assets that could have a material effect on the financial statements and (ii) such
that all material information is accumulated and communicated to its management as appropriate to allow timely decisions regarding required
disclosure and to make the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Except as specifically noted herein, nothing disclosed in the PubCo SEC Documents shall be deemed to be a qualification of, or modification
to, the representations and warranties in this <U>Article IV</U>.</FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.07 <FONT STYLE="color: black; vertical-align: baseline">Undisclosed Liabilities. </FONT></B>As of the date of this Agreement, except
as set forth in <U>Section 4.07</U> of the PubCo Disclosure Letter, there are no Liabilities of PubCo or any of its Subsidiaries, individually
or in the aggregate, that are required to be recorded or reflected on a balance sheet prepared in accordance with GAAP, other than:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Liabilities reflected or reserved against in the consolidated balance sheet of PubCo and its consolidated Subsidiaries as of December
31, 2024 or the footnotes thereto set forth in the PubCo SEC Documents;</FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Liabilities incurred since December 31, 2024 in the ordinary course of business (none of which is a Liability for tort, breach of contract
or environmental Liability);</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Liabilities incurred in connection with the Share Exchange or as permitted or contemplated expressly by this Agreement; and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Liabilities that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on PubCo.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.08 <FONT STYLE="color: black; vertical-align: baseline">Legal Proceedings.</FONT></B> Except as set forth in the PubCo SEC Documents
or in <U>Section 4.08 of the PubCo Disclosure Letter</U>, (a) there are no Actions pending or, to PubCo&rsquo;s knowledge, threatened
against or by PubCo or any Affiliate of PubCo or any of their assets or properties that would, individually or in the aggregate, reasonably
be expected to be material to PubCo and its Subsidiaries, (b) there are no Orders outstanding against PubCo and its Subsidiaries or any
of their assets or properties that would, individually or in the aggregate, reasonably be expected to be material to PubCo and its Subsidiaries,
and (c) no Action pending or, to PubCo&rsquo;s knowledge, threatened against or by PubCo or any Affiliate of PubCo, that challenge or
seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement. No event has occurred or circumstances exist
that may give rise or serve as a basis for any such Action.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
4.09 Taxes. </B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All Tax Returns required to be filed by PubCo have been, or will be, timely filed. Such Tax Returns are, or will be, true, complete and
correct in all material respects. All Taxes due and owing by PubCo (whether or not shown on any Tax Return) have been, or will be, timely
paid.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
PubCo has withheld and paid each Tax required to have been withheld and paid in connection with amounts paid or owing to any employee,
independent contractor, creditor, customer, shareholder or other party, and complied with all information reporting and backup withholding
provisions of applicable Law in all material respect.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No claim has been made by any taxing authority against PubCo in any jurisdiction where PubCo may be subject to Tax by that jurisdiction.</FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.10 Nasdaq Listing</B>. Shares of the PubCo Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed
on the Nasdaq Global Market under the symbol &ldquo;LIXT&rdquo;. PubCo is in compliance in all material respects with the rules of Nasdaq
and there is no Action or proceeding pending or, to the knowledge of PubCo, threatened against PubCo by Nasdaq or the SEC with respect
to any intention by such entity to deregister the PubCo Common Stock or terminate the listing of the PubCo Common Stock on Nasdaq. None
of PubCo nor any of its Affiliates or Representatives has taken any action to terminate the registration of the PubCo Common Stock under
the Exchange Act except as expressly contemplated by this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE V</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Covenants</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.01 <FONT STYLE="color: black; vertical-align: baseline">Conduct of Business Prior to the Closing.</FONT></B> From the date hereof until
the Closing, except as otherwise provided in this Agreement or consented to in writing by the other party hereto (which consent shall
not be unreasonably withheld, conditioned or delayed), each of the PubCo and the Company shall, (x) conduct their respective business
in the ordinary course of business consistent with past practice; and (y) use reasonable best efforts to maintain and preserve intact
the current organization, business and franchise of such company and to preserve the rights, franchises, goodwill and relationships of
its employees, customers, lenders, suppliers, regulators and others having business relationships with such company.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
5.02 Access to Information.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date hereof
until the Closing, each party hereto shall, (a) afford the other party and its Representatives full and free access to and the right
to inspect all of the properties, assets, premises, books and records, Contracts and other documents and data related to such company;
and (b) furnish such requesting party and its Representatives with such financial, operating and other data and information related to
the PubCo, the Company and their respective Subsidiaries, as the requesting party or any of its Representatives may reasonably request.
Any investigation pursuant to this <U>Section 5.02</U> shall be conducted in such manner as not to interfere unreasonably with the conduct
of the business of any party hereto. No investigation by any party hereto shall operate as a waiver or otherwise affect any representation,
warranty or agreement given or made by the other parties in this Agreement. PubCo and Seller shall comply with and shall use their reasonable
best efforts to cause their respective Representatives to comply with, all of their respective obligations under any applicable confidentiality
agreement to which they are subject, with respect to the information disclosed under this <U>Section 5.02</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.03 <FONT STYLE="color: black; vertical-align: baseline">No Solicitation of Other Bids.</FONT></B> Neither the Company nor Seller shall,
and shall not authorize or permit any of their respective Affiliates or any of its or their Representatives to, directly or indirectly,
(i) encourage, solicit, initiate, facilitate or continue inquiries regarding an Acquisition Proposal with respect to the Company; (ii)
enter into discussions or negotiations with, or provide any information to, any Person concerning a possible Acquisition Proposal with
respect to the Company; or (iii) enter into any agreements or other instruments (whether or not binding) regarding an Acquisition Proposal
with respect to the Company. The Company and Seller shall immediately cease and cause to be terminated, and shall cause their respective
Affiliates and all of its and their respective Representatives to immediately cease and cause to be terminated, all existing discussions
or negotiations with any Persons conducted heretofore with respect to, or that could lead to, an Acquisition Proposal. For purposes hereof,
&ldquo;<B>Acquisition Proposal</B>&rdquo; shall mean any inquiry, proposal or offer from any Person concerning (i) a merger, consolidation,
liquidation, recapitalization, share exchange or other business combination transaction involving the Company; (ii) the issuance or acquisition
of shares of capital stock or other equity securities of the Company <FONT STYLE="color: windowtext">pursuant to which such third-party
purchaser directly or indirectly acquires beneficial or record ownership of securities representing more than 50% of the outstanding
securities of any class of voting securities of a party</FONT>; or (iii) the sale, lease, exchange or other disposition of any significant
portion of the Company&rsquo;s properties or assets, respectively.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.04 Notice of Certain Events.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until the Closing, Seller or the Company shall promptly notify PubCo in writing of:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any fact, circumstance, event or action the existence, occurrence or taking of which (A) has had, or could reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on the Company, or (B) has resulted in, or could reasonably be expected
to result in, the failure of any of the conditions set forth in <U>Section 7.02</U> to be satisfied;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the
completion the Share Exchange contemplated by this Agreement; and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any notice or other communication from any Governmental Authority in connection with the completion of the Share Exchange contemplated
by this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
PubCo&rsquo;s receipt of information pursuant to this <U>Section 5.04</U> shall not operate as a waiver or otherwise affect any representation,
warranty or agreement given or made by Seller in this Agreement (including <U>Section 8.02</U> and <U>Section 9.01</U>) and shall not
be deemed to amend or supplement the Seller&rsquo;s Disclosure Letter unless otherwise agreed.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.05 Governmental and Other Approvals and Consents.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each party hereto shall, as promptly as possible, (i) make, or cause or be made, all filings and submissions required under any Law applicable
to such party or any of its Affiliates; and (ii) use reasonable best efforts to obtain, or cause to be obtained, all consents, authorizations,
orders and approvals from all Governmental Authorities that may be or become necessary for its execution and delivery of this Agreement
and the performance of its obligations pursuant to this Agreement and the Ancillary Documents. Each party shall cooperate fully with
the other party and its Affiliates in promptly seeking to obtain all such consents, authorizations, orders and approvals. The parties
hereto shall not willfully take any action that will have the effect of delaying, impairing or impeding the receipt of any required consents,
authorizations, orders and approvals.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Seller and PubCo shall use reasonable best efforts to give all notices to, and obtain all consents from, all third parties that are described
in <U>Section 3.05</U> and <U>Section 4.02</U> of the Disclosure Schedules as promptly as practicable after the Closing and prior to
the PubCo Stockholder Meeting.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Without limiting the generality of the parties&rsquo; undertakings pursuant to subsections (a) and (b) above, each of the parties hereto
shall use all reasonable best efforts to:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
respond to any inquiries by any Governmental Authority regarding any matters with respect to the transactions contemplated by this Agreement
or any Ancillary Document;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
avoid the imposition of any order or the taking of any action that would restrain, alter or enjoin the transactions contemplated by this
Agreement or any Ancillary Document; and</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
in the event any Governmental Order adversely affecting the ability of the parties to consummate the transactions contemplated by this
Agreement or any Ancillary Document has been issued, to have such Governmental Order vacated or lifted.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If any consent, approval or authorization necessary to preserve any right or benefit under any Contract to which the Company is a party
is not obtained prior to the Closing, Seller shall, subsequent to the Closing, cooperate with PubCo and the Company in attempting to
obtain such consent, approval or authorization as promptly thereafter as practicable. If such consent, approval or authorization cannot
be obtained, Seller shall use their reasonable best efforts to provide the Company with the rights and benefits of the affected Contract
for the term thereof, and, if Seller provides such rights and benefits, the Company, respectively, shall assume all obligations and burdens
thereunder.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
All analyses, appearances, meetings, discussions, presentations, memoranda, briefs, filings, arguments, and proposals made by or on behalf
of either party before any Governmental Authority or the staff or regulators of any Governmental Authority, in connection with the transactions
contemplated hereunder shall be disclosed to the other party hereunder in advance of any filing, submission or attendance, it being the
intent that the parties will consult and cooperate with one another, and consider in good faith the views of one another, in connection
with any such analyses, appearances, meetings, discussions, presentations, memoranda, briefs, filings, arguments, and proposals. Each
party shall give notice to the other party with respect to any meeting, discussion, appearance or contact with any Governmental Authority
or the staff or regulators of any Governmental Authority, with such notice being sufficient to provide the other party with the opportunity
to attend and participate in such meeting, discussion, appearance or contact.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
5.06 Closing Conditions</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date hereof until
the Closing, each party hereto shall use its reasonable best efforts to take such actions as are necessary to expeditiously satisfy the
closing conditions set forth in <U>ARTICLE VII</U> hereof that are applicable to it.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
5.07 Public Announcements.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise required
by applicable Law or stock exchange requirements (based upon the reasonable advice of counsel), no party to this Agreement shall make
any public announcements in respect of this Agreement or the transactions contemplated hereby or otherwise communicate with any news
media without the prior written consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed),
and the parties shall cooperate as to the timing and contents of any such announcement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
5.08 Conversion of Series C Preferred Stock Limitations; PubCo Shareholder Approval</B><FONT STYLE="font-weight: normal">. Seller hereby
agrees that notwithstanding anything in the Series C Preferred Stock Designation to the contrary, until such time as PubCo has obtained
the </FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PubCo Shareholder Approval, neither the Seller,
nor any transferee of the Exchanged Preferred Shares, shall be entitled to convert such Exchanged Preferred Shares into Exchanged Common
Shares that in the aggregate exceed 19.99% of the issued and outstanding shares of PubCo Common Stock. The Exchanged Preferred Shares
shall bear a legend with respect to such limitation. PubCo shall seek to obtain the PubCo Shareholder Approval for the conversion of
the Exchanged Preferred Shares into the aggregate number of Exchanged Common Shares at the 2026 Annual PubCo Stockholder Meeting.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
5.09 Audit. </B><FONT STYLE="font-weight: normal">From and after the Closing, Seller agrees to cooperate with PubCo and PubCo&rsquo;s
auditors in conducting any audit of the Company&rsquo;s financial statements that may be required under Applicable Law for the period
prior to Closing (the &ldquo;</FONT><B>Audit</B><FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.10 <FONT STYLE="color: black; vertical-align: baseline">Further Assurances.</FONT></B> Following the Closing, each of the parties hereto
shall, and shall cause their respective Affiliates to, execute and deliver such additional documents, instruments, conveyances and assurances
and take such further actions as may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated
by this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[RESERVED]</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Conditions
to closing</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
7.01 Conditions to Obligations of All Parties.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of each party to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment, at or prior
to the Closing, of each of the following conditions:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Governmental Order which is in effect and
has the effect of making the transactions contemplated by this Agreement illegal, otherwise restraining or prohibiting consummation of
such transactions or causing any of the transactions contemplated hereunder to be rescinded following completion thereof.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Seller and the Company shall have received all consents, authorizations, orders and approvals from the Governmental Authorities referred
to in <U>Section 3.05</U> and <U>Section 5.08</U> and PubCo shall have received all consents, authorizations, orders and approvals from
the Governmental Authorities referred to in <U>Section 4.02</U>, in each case, in form and substance reasonably satisfactory to PubCo
and Seller, as the case may be, and none of such consent, authorization, order and approval shall have been revoked as of the Closing
Date.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
7.02 Conditions to Obligations of PubCo.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligations
of PubCo to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or PubCo&rsquo;s waiver, at
or prior to the Closing, of each of the following conditions:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The representations and warranties of Seller contained in this Agreement and the Ancillary Documents shall be true and correct in all
respects on and as of the date hereof and on and as of the Closing Date with the same effect as though made at and as of such date (except
those representations and warranties that address matters only as of a specified date, the accuracy of which shall be determined as of
that specified date in all respects), except where the failure of such representations and warranties to be so true and correct would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Seller&rsquo;s ability to consummate
the transactions contemplated by this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Seller and the Company shall have duly performed and complied in all material respects with all agreements and covenants required by
this Agreement and each of the Ancillary Documents to be performed or complied with by it prior to or on the Closing Date.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No Action shall have been commenced against PubCo, Seller, or the Company, which would prevent the Closing. No injunction or restraining
order shall have been issued by any Governmental Authority, and be in effect, which restrains or prohibits any transaction contemplated
hereby.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Ancillary Documents shall have been executed and delivered by the parties thereto and true and complete copies thereof shall have
been delivered to PubCo.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The closings under the Liora Asset Purchase Agreement and the Orbit Purchase Agreement shall have been consummated in accordance with
their respective terms and no default of any party thereto shall have occurred.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Liora Lease shall have been executed by all parties thereto and be in full force and effect.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Agent shall have delivered to PubCo a good standing certificate (or its equivalent) for the Company from the secretary of state or similar
Governmental Authority of the jurisdiction under the Laws in which the Company is organized.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
PubCo shall have received a certificate, dated the Closing Date and signed by Seller, that each of the conditions set forth in <U>Section
7.02(a)</U> and <U>Section 7.02(b)</U> have been satisfied.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
7.03 Conditions to Obligations of Seller.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligations
of Seller to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or Seller&rsquo;s waiver,
at or prior to the Closing, of each of the following conditions:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The representations and warranties of PubCo contained in this Agreement and the Ancillary Documents shall be true and correct in all
respects on and as of the date hereof and on and as of the Closing Date with the same effect as though made at and as of such date (except
those representations and warranties that address matters only as of a specified date, the accuracy of which shall be determined as of
that specified date in all respects), except where the failure of such representations and warranties to be so true and correct would
not reasonably be expected to have, individually or in the aggregate, a material adverse effect on PubCo&rsquo;s ability to consummate
the transactions contemplated by this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
PubCo shall have duly performed and complied in all material respects with all agreements and covenants required by this Agreement and
each of the Ancillary Documents to be performed or complied with by it prior to or on the Closing Date; <I>provided, that</I>, with respect
to agreements and covenants that are qualified by materiality, PubCo shall have performed such agreements and covenants, as so qualified,
in all respects.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No injunction or restraining order shall have been issued by any Governmental Authority, and be in effect, which restrains or prohibits
any material transaction contemplated hereby.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Ancillary Documents shall have been executed and delivered by the parties thereto and complete copies thereof shall have been delivered
to Seller.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
PubCo shall have filed the Certificate of Designation with respect to the Series C Preferred Stock with the Secretary of State of Delaware.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Seller shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of PubCo, that each of the conditions
set forth in <U>Section 7.03(a)</U> and <U>Section 7.03(b)</U> have been satisfied.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Seller shall have received a certificate of the Secretary or an Assistant Secretary (or equivalent officer) of PubCo certifying that
attached thereto are true and complete copies of all resolutions adopted by the board of directors of PubCo authorizing the execution,
delivery and performance of this Agreement and the Ancillary Documents to which it is a party and the consummation of the transactions
contemplated hereby and thereby, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection
with the transactions contemplated hereby and thereby.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Seller shall have received a certificate of the Secretary or an Assistant Secretary (or equivalent officer) of PubCo certifying the names
and signatures of the officers of PubCo authorized to sign this Agreement, the Ancillary Documents and the other documents to be delivered
hereunder and thereunder.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Shares of the PubCo Common Stock remain listed on the Nasdaq Global Market.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Indemnification</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
8.01 Survival.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the limitations and other
provisions of this Agreement, the representations and warranties of the Seller contained herein shall survive the Closing and shall remain
in full force and effect until the date that is 18 months from the Closing Date; <I>provided, that</I> the representations and warranties
of Seller in <U>Section 3.01</U>, <U>Section 3.02</U>, <U>Section 3.03</U>, <U>Section 3.04</U>, <U>Section 3.07</U>, <U>Section 3.09</U>
and <U>Section 3.20</U> (collectively, the &ldquo;<B>Seller Fundamental Representations</B>&rdquo;) shall survive indefinitely. Subject
to the limitations and other provisions of this Agreement, the representations and warranties of the PubCo contained herein shall survive
the Closing and shall remain in full force and effect until the date that is 30 days after the PubCo files its Form 10-K for its fiscal
year ending December 31, 2026; <I>provided, that</I> the representations and warranties in <U>Section 4.01, Section 4.02</U> and <U>Section
4.04</U> (collectively, the &ldquo;<B>PubCo Fundamental Representations</B>&rdquo;) shall survive indefinitely. All covenants and agreements
of the parties contained herein (other than any covenants or agreements contained in <U>ARTICLE VI</U> which are subject to <U>ARTICLE
VI</U>) shall survive the Closing indefinitely or for the period explicitly specified therein. Notwithstanding the foregoing, any claims
asserted in good faith with reasonable specificity (to the extent known at such time) and in writing by notice from the non-breaching
party to the breaching party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration
of the relevant representation or warranty and such claims shall survive until finally resolved.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
8.02 Indemnification By Seller.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the other
terms and conditions of this <U>ARTICLE VIII</U>, from and after Closing, Seller shall severally and not jointly indemnify and defend
each of PubCo and its Affiliates (including the Company after the Closing) and their respective Representatives (collectively, the &ldquo;<B>PubCo
Indemnitees</B>&rdquo;) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for,
any and all Losses incurred or sustained by, or imposed upon, the PubCo Indemnitees based upon, arising out of, with respect to or by
reason of:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any inaccuracy in or breach of any of the representations or warranties of Seller contained in <U>ARTICLE III</U> of this Agreement or
in any certificate or instrument delivered by or on behalf of Seller pursuant to this Agreement; or</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any breach or non-fulfillment of any covenant, agreement or obligation to be performed by Seller pursuant to this Agreement</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
8.03 Indemnification By PubCo.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to the other
terms and conditions of this <U>ARTICLE VIII</U>, from and after Closing, PubCo shall indemnify and defend the Seller (including the
Company if before the Closing) and their respective Affiliates and their respective Representatives (collectively, the &ldquo;<B>Seller
Indemnitees</B>&rdquo;) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for,
any and all Losses incurred or sustained by, or imposed upon, the Seller Indemnitees based upon, arising out of, with respect to or by
reason of:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any inaccuracy in or breach of any of the representations or warranties of PubCo contained in <U>ARTICLE IV</U> of this Agreement or
in any certificate or instrument delivered by or on behalf of PubCo pursuant to this Agreement; or</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any breach or non-fulfillment of any covenant, agreement or obligation to be performed by PubCo pursuant to this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
8.04 Certain Limitations.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indemnification provided
for in <U>Section 8.02</U> and <U>Section 8.03</U> shall be subject to the following limitations:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Seller shall not be liable to the PubCo Indemnitees for indemnification under <U>Section 8.02(a)</U> until the aggregate amount of all
Losses in respect of indemnification under <U>Section 8.02(a)</U> exceeds $50,000 (the &ldquo;<B>Basket</B>&rdquo;), in which event Seller
shall be required to pay or be liable for all such Losses from the first dollar. The aggregate amount of all Losses for which Seller
shall be liable pursuant to Section 8.02(a) shall not exceed $6,500,000 (the &ldquo;<B>Cap</B>&rdquo;).</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
PubCo shall not be liable to the Seller Indemnitees for indemnification under <U>Section 8.03(a)</U> until the aggregate amount of all
Losses in respect of indemnification under Section 8.03(a) exceeds the Basket, in which event PubCo shall be required to pay or be liable
for all such Losses from the first dollar. The aggregate amount of all Losses for which PubCo shall be liable pursuant to <U>Section
8.03(a)</U> shall not exceed the Cap.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, the limitations set forth in <U>Section 8.04(a)</U> and <U>Section 8.04(b)</U> shall not apply to Losses
based upon, arising out of, with respect to or by reason of any inaccuracy in or breach of any Seller Fundamental Representation or PubCo
Fundamental Representation, respectively.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
8.05 Indemnification Procedures.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The party making
a claim under this <U>ARTICLE VIII</U> is referred to as the &ldquo;<B>Indemnified Party</B>&rdquo;, and the party against whom such
claims are asserted under this <U>ARTICLE VIII</U> is referred to as the &ldquo;<B>Indemnifying Party</B>&rdquo;.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Third-Party Claims. If any Indemnified Party receives notice of the assertion or commencement of any Action made or brought by any Person
who is not a party to this Agreement or an Affiliate of a party to this Agreement or a Representative of the foregoing (a &ldquo;<B>Third-Party
Claim</B>&rdquo;) against such Indemnified Party with respect to which the Indemnifying Party is obligated to provide indemnification
under this Agreement, the Indemnified Party shall give the Indemnifying Party reasonably prompt written notice thereof, but in any event
not later than 30 calendar days after receipt of such notice of such Third-Party Claim. The failure to give such prompt written notice
shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying
Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the Third-Party Claim
in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably
practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have the right to participate
in, or by giving written notice to the Indemnified Party, to assume the defense of any Third-Party Claim at the Indemnifying Party&rsquo;s
expense and by the Indemnifying Party&rsquo;s own counsel, and the Indemnified Party shall cooperate in good faith in such defense; <I>provided,
that</I> if the Indemnifying Party is a Seller, such Indemnifying Party shall not have the right to defend or direct the defense of any
such Third-Party Claim that (x) is asserted directly by or on behalf of a Person that is a supplier or customer of the Company, or (y)
the Third-party Claim is brought in a jurisdiction other than the Republic of the Philippines. In the event that the Indemnifying Party
assumes the defense of any Third-Party Claim, subject to <U>Section 8.05(b)</U>, it shall have the right to take such action as it deems
necessary to avoid, dispute, defend, appeal or make counterclaims pertaining to any such Third-Party Claim in the name and on behalf
of the Indemnified Party. The Indemnified Party shall have the right to participate in the defense of any Third-Party Claim with counsel
selected by it subject to the Indemnifying Party&rsquo;s right to control the defense thereof. The fees and disbursements of such counsel
shall be at the expense of the Indemnified Party, <I>provided, that</I> if in the reasonable opinion of counsel to the Indemnified Party,
(A) there are legal defenses available to an Indemnified Party that are different from or additional to those available to the Indemnifying
Party; or (B) there exists a conflict of interest between the Indemnifying Party and the Indemnified Party that cannot be waived, the
Indemnifying Party shall be liable for the reasonable fees and expenses of counsel to the Indemnified Party in each jurisdiction for
which the Indemnified Party determines counsel is required. If the Indemnifying Party elects not to compromise or defend such Third-Party
Claim, fails to promptly notify the Indemnified Party in writing of its election to defend as provided in this Agreement, or fails to
diligently prosecute the defense of such Third-Party Claim, the Indemnified Party may, subject to <U>Section 8.05(b)</U>, pay, compromise,
defend such Third-Party Claim and seek indemnification for any and all Losses based upon, arising from or relating to such Third-Party
Claim. Seller and PubCo shall cooperate with each other in all reasonable respects in connection with the defense of any Third-Party
Claim, including making available (subject to the provisions of <U>Section 5.06</U>) records relating to such Third-Party Claim and furnishing,
without expense (other than reimbursement of actual out-of-pocket expenses) to the defending party, management employees of the non-defending
party as may be reasonably necessary for the preparation of the defense of such Third-Party Claim.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Settlement of Third-Party Claims. Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not enter into
settlement of any Third-Party Claim without the prior written consent of the Indemnified Party, except as provided in this <U>Section
8.05(b)</U>. If a firm offer is made to settle a Third-Party Claim without leading to Liability or the creation of a financial or other
obligation on the part of the Indemnified Party and provides, in customary form, for the unconditional release of each Indemnified Party
from all Liabilities and obligations in connection with such Third-Party Claim and the Indemnifying Party desires to accept and agree
to such offer, the Indemnifying Party shall give written notice to that effect to the Indemnified Party. If the Indemnified Party fails
to consent to such firm offer within ten days after its receipt of such notice, the Indemnified Party may continue to contest or defend
such Third-Party Claim and in such event, the maximum liability of the Indemnifying Party as to such Third-Party Claim shall not exceed
the amount of such settlement offer. If the Indemnified Party fails to consent to such firm offer and also fails to assume defense of
such Third-Party Claim, the Indemnifying Party may settle the Third-Party Claim upon the terms set forth in such firm offer to settle
such Third-Party Claim. If the Indemnified Party has assumed the defense pursuant to <U>Section 8.05(a)</U>, it shall not agree to any
settlement without the written consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed).</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Direct Claims. Any Action by an Indemnified Party on account of a Loss which does not result from a Third-Party Claim (a &ldquo;<B>Direct
Claim</B>&rdquo;) shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof,
but in any event not later than 30 days after the Indemnified Party becomes aware of such Direct Claim. The failure to give such prompt
written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that
the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the
Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount,
if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have
30 days after its receipt of such notice to respond in writing to such Direct Claim. The Indemnified Party shall allow the Indemnifying
Party and its professional advisors to investigate the matter or circumstance alleged to give rise to the Direct Claim, and whether and
to what extent any amount is payable in respect of the Direct Claim and the Indemnified Party shall assist the Indemnifying Party&rsquo;s
investigation by giving such information and assistance (including access to the Company&rsquo;s premises and personnel and the right
to examine and copy any accounts, documents or records) as the Indemnifying Party or any of its professional advisors may reasonably
request. If the Indemnifying Party does not so respond within such 30-day period, the Indemnifying Party shall be deemed to have rejected
such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on
the terms and subject to the provisions of this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
8.06 Tax Treatment of Indemnification Payments.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
indemnification payments made under this Agreement shall be treated by the parties as an adjustment to the Purchase Price for Tax purposes,
unless otherwise required by Law.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.07 <FONT STYLE="color: black; vertical-align: baseline">Effect of Investigation.</FONT></B> The representations, warranties and covenants
of the Indemnifying Party, and the Indemnified Party&rsquo;s right to indemnification with respect thereto, shall not be affected or
deemed waived by reason of any investigation made by or on behalf of the Indemnified Party (including by any of its Representatives)
or by reason of the fact that the Indemnified Party or any of its Representatives knew or should have known that any such representation
or warranty is, was or might be inaccurate or by reason of the Indemnified Party&rsquo;s waiver of any condition set forth in <U>Section
7.02</U> or <U>Section 7.03</U>, as the case may be.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Miscellaneous</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.01 Expenses.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as otherwise expressly provided
herein, all costs and expenses, including, without limitation, fees and disbursements of counsel, financial advisors and accountants,
incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and
expenses, whether or not the Closing shall have occurred.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.02 Notices.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All notices, requests, consents, claims,
demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given (a) when delivered by
hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier
(receipt requested); (c) on the date sent by e-mail of a PDF document (with confirmation of transmission) if sent during normal business
hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient; or (d) on the third day after
the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the
respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance
with this <U>Section 9.02</U>):</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Seller:</FONT><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 65%"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orbit
                                            Capital Inc.</FONT></P>
                                                                                                <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C/O
                                            Cayman International Corporate and Marine Services Ltd.</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.O.
    Box 822, George Town, Grand Cayman KY1-1003, Cayman Islands</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention
: Jason Butcher</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to PubCo:</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">433
                                            Plaza Real, Suite 275</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca
    Raton, FL 33432</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    gpursglove@lixte.com</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Geordan Pursglove</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>
                                                                                                <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            a copy to:</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif">Sichenzia Ross Ference Carmel LLP
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
    Avenue of the Americas</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10036</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    rcarmel@srfc.law</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Ross Carmel</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.03 Interpretation.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of this Agreement,
unless otherwise expressly provided, (a) the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo; shall be
deemed to be followed by the words &ldquo;without limitation&rdquo;; (b) the word &ldquo;or&rdquo; is not exclusive; (c) the words &ldquo;herein,&rdquo;
&ldquo;hereof,&rdquo; &ldquo;hereby,&rdquo; &ldquo;hereto&rdquo; and &ldquo;hereunder&rdquo; refer to this Agreement as a whole; and
(d) references herein: (i) to Articles, Sections, Disclosure Schedules and Exhibits mean the Articles and Sections of, and Disclosure
Schedules and Exhibits attached to, this Agreement; (ii) to an agreement, instrument or other document means such agreement, instrument
or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof and (iii)
to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated
thereunder. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against
the party drafting an instrument or causing any instrument to be drafted. The Disclosure Schedules and Exhibits referred to herein shall
be construed with, and as an integral part of, this Agreement to the same extent as if they were set forth verbatim herein.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.04 Headings.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The headings in this Agreement are
for reference only and shall not affect the interpretation of this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.05 Severability.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any term or provision of this
Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect
any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction.
Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable
manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.06 Entire Agreement.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement and the Ancillary
Documents constitute the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein
and therein, and supersede all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject
matter. In the event of any inconsistency between the statements in the body of this Agreement and those in the Ancillary Documents,
the Exhibits and Disclosure Schedules (other than an exception expressly set forth as such in the Disclosure Schedules), the statements
in the body of this Agreement will control.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.07 Successors and Assigns.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement shall
be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither party
may assign its rights or obligations hereunder without the prior written consent of the other party, which consent shall not be unreasonably
withheld, conditioned or delayed; <I>provided, however</I>, that prior to the Closing Date, PubCo may, without the prior written consent
of Seller, assign all or any portion of its rights under this Agreement to one or more of its direct or indirect wholly-owned subsidiaries.
No assignment shall relieve the assigning party of any of its obligations hereunder.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.08 No Third-Party Beneficiaries.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as provided
in <U>ARTICLE VIII</U>, this Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns
and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or
remedy of any nature whatsoever under or by reason of this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.09 Amendment and Modification; Waiver.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement
may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of
the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any
party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written
waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay
in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor
shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof
or the exercise of any other right, remedy, power or privilege.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>Section
9.10 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect
to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction).</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF THE STATE OF DELAWARE IN EACH
CASE LOCATED IN COUNTY OF KENT, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION
OR PROCEEDING. SERVICE OF PROCESS, SUMMONS, NOTICE OR OTHER DOCUMENT BY MAIL TO SUCH PARTY&rsquo;S ADDRESS SET FORTH HEREIN SHALL BE
EFFECTIVE SERVICE OF PROCESS FOR ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT IN ANY SUCH COURT. THE PARTIES IRREVOCABLY AND UNCONDITIONALLY
WAIVE ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR ANY PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT TO
PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT
FORUM.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE ANCILLARY DOCUMENTS IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS
CONTEMPLATED HEREBY OR THEREBY. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL
ACTION, (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) SUCH PARTY
HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION 9.10(c)</U>.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.11 Specific Performance.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The parties agree that
irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the
parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy to which they are entitled at
law or in equity.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.12 <FONT STYLE="color: black; vertical-align: baseline">No Presumption Against Drafting Party. </FONT></B><FONT STYLE="color: black; vertical-align: baseline"><FONT STYLE="font-weight: normal">PubCo
and Seller agree and acknowledge that this Agreement has been freely negotiated by both parties at arm&rsquo;s length between Persons
sophisticated and knowledgeable in the matters dealt with herein, and that e</FONT></FONT>ach party has had an opportunity to consult
with an attorney in reviewing and drafting this Agreement. PubCo and Seller further <FONT STYLE="font-weight: normal; color: black; vertical-align: baseline">agree
that in any controversy, dispute, or contest over the meaning, interpretation, validity, or enforceability of this Agreement or any of
its terms or conditions, there shall be no inference, presumption, or conclusion drawn whatsoever against either party by virtue of that
party having drafted this Agreement or any portion thereof</FONT><FONT STYLE="color: #242424; background-color: white">.</FONT></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black; vertical-align: baseline"><B>Section
9.13 Counterparts.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement may be executed
in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement.
A signed copy of this Agreement delivered by e-mail or other means of electronic transmission shall be deemed to have the same legal
effect as delivery of an original signed copy of this Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; vertical-align: baseline"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
page follows]</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by their duly authorized
officers or representatives.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PUBCO:</FONT></TD>
</TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIXTE
                                            BIOTECHNOLOGY HOLDINGS, INC</B></FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
                                         <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                         Geordan Pursglove&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
                                         <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geordan
                                         Pursglove</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
                                         <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
                                            COMPANY:</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIORA
                                            TECHNOLOGIES EUROPE LTD.</B></FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
                                         <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                         Sidney Braun</I></FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
                                         <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney
                                         Braun</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
                                         <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLER:</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ORBIT
                                            CAPITAL INC.</B></FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
                                         <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                         Jason Butcher</I></FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
                                         <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
                                         Butcher</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
                                         <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
1</U></B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSETS
OWNED BY THE COMPANY</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Owned IP and Goodwill;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Technology;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Hardware;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Software;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
digital assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
Machines and related components;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
Commercial Records;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
the Name (but noting that the Seller may continue operating under the Name until its dissolution);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
All know-how, working papers, files and records related to Owned IP, Technology, Hardware, Software, digital assets and Machines; and&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
all (if any) of the other assets, property or rights of the Seller exclusively or predominantly relating to the Business and which are
not otherwise described, but not the Excluded Assets,</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this <U>Schedule 1</U>, the capitalized terms set forth above shall have the meaning set forth in the Liora Asset Purchase
Agreement.</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ROYALTY
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
ROYALTY AGREEMENT</B> (this &ldquo;<B>Royalty Agreement</B>&rdquo;), dated as of November 24, 2025, is by and between Lixte Biotechnology
Holdings, Inc., a Delaware company (the &ldquo;<B>Company</B>&rdquo;), and Orbit Capital Inc., a Cayman Islands corporation (the &ldquo;<B>Royalty
Holder</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS
</B>the Company, the Royalty Holder, and Liora Technologies Europe Ltd., a corporation organized under the laws of England and Wales
(&ldquo;<B>Liora</B>&rdquo;), entered into a Share Exchange Agreement on November 21, 2025, which provided that the Company shall pay
the Royalty to the Royalty Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE, </B>for good and valuable consideration (the receipt and sufficiency of which is acknowledged by each of the Parties), the
Parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
1<BR>
Interpretation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions<FONT STYLE="font-weight: normal">.
                                            In this Royalty Agreement, unless otherwise indicated, capitalized terms shall have the meanings
                                            set forth below.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
                                            means any Person that directly or indirectly controls, is controlled by, or is under common
                                            control with, a Party. For purposes of the preceding sentence, &ldquo;<B>control</B>&rdquo;
                                            means possession, directly or indirectly, of the power to direct or cause direction of management
                                            and policies through ownership of voting securities, contract, voting trust or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
                                            Laws</B>&rdquo; or &ldquo;<B>Laws</B>&rdquo; in respect of any Person, property, transaction
                                            or event, means all laws, statutes, treaties, regulations, and enforceable judgments, orders
                                            and decrees applicable to that Person, property, transaction or event and, in each case having
                                            the force of law, all applicable official directives, rules, protocols, consents, approvals,
                                            authorizations, guidelines, orders and policies of any governmental body having or purporting
                                            to have authority over that Person, property, transaction or event;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
                                            Day</B>&rdquo; means a day that is not a Saturday, Sunday or any other day which is a statutory
                                            holiday or a bank holiday in New York, United States;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Confidential
                                            Information</B>&rdquo; has the meaning provided in Subsection 6.1(1);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company
                                            Equipment</B>&rdquo; means the machine and technology set forth on <U>Schedule I</U> attached
                                            hereto.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Governmental
                                            Authority</B>&rdquo; means any national, state, regional, municipal or local government,
                                            governmental department, commission, board, bureau, agency, authority or instrumentality,
                                            or any Person exercising executive, legislative, judicial, regulatory or administrative functions
                                            of or pertaining to any of the foregoing entities, including all tribunals, commissions,
                                            boards, bureaux, arbitrators and arbitration panels, and any authority or other Person controlled
                                            by any of the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Net
                                            Revenue</B>&rdquo; means the amount of gross revenue received by the Company or its Affiliate
                                            derived from (i) the operation or use of the Company Equipment, (ii) the licensing of the
                                            Company Equipment to any third-parties, and (iii) any consideration received from the sale
                                            or other monetization or commercialization of the Company Equipment, less direct and indirect
                                            expenses, charges, taxes and any other customary out-of-pocket costs attributable to such
                                            gross revenue. For the avoidance of doubt, Net Revenue shall be calculated in accordance
                                            with U.S. Generally Accepted Accounting Principles (&ldquo;<B>GAAP</B>&rdquo;), consistently
                                            applied.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Notice</B>&rdquo;
                                            has the meaning provided in Section 8.5;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Operations
                                            Report</B>&rdquo; has the meaning provided in Section 3.3;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Parties</B>&rdquo;
                                            means the parties to this Royalty Agreement and &ldquo;<B>Party</B>&rdquo; means any one
                                            of them;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
                                            means an individual, a partnership, a corporation, a Governmental Authority, a trustee, any
                                            unincorporated organization and the heirs, executors, administrators or other legal representatives
                                            of an individual and words importing &ldquo;Person&rdquo; have similar meaning;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Quarter</B>&rdquo;
                                            and &ldquo;<B>Quarterly</B>&rdquo; mean the period commencing on the date that the Company
                                            first receives Net Revenue and expiring on the day preceding the next occurring 1st day of
                                            January, April, July or October and thereafter each successive period of three calendar months;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Royalty</B>&rdquo;
                                            means the payments to be made to the Royalty Holder by the Company in respect of Net Revenue
                                            pursuant to this Royalty Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Royalty
                                            Agreement</B>&rdquo; means this Royalty Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Royalty
                                            Holder</B>&rdquo; means the Royalty Holder (as defined in the recitals to this Royalty Agreement),
                                            its Affiliates or successors in interest, including without limitation any assignees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Royalty
                                            Payment Cap</B>&rdquo; means Royalty payments in the aggregate amount of $45,000,000 paid
                                            pursuant to this Royalty Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Share
                                            Exchange Agreement</B>&rdquo; means the Share Exchange Agreement dated as of November 21,
                                            2025 by and among Orbit Capital Inc., a Cayman Islands corporation, Liora Technologies Europe
                                            Ltd., a corporation organized under the laws of England and Wales, and Lixte Biotechnology
                                            Holdings, Inc., a Delaware corporation, as it may be further amended, restated, amended and
                                            restated, supplemented or modified from time to time on or after the date hereof; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Taxes</B>&rdquo;
                                            means all foreign and domestic federal, provincial, state, municipal and other governmental
                                            taxes, levies, imposts, deductions, charges, claims, and assessments and withholdings, and
                                            all liabilities with respect thereto (including, without limitation, interest and penalties).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
2<BR>
Royalty</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
Royalty<FONT STYLE="font-weight: normal">. The Company hereby grants and reserves for the benefit of the Royalty Holder the Royalty,
and covenants to pay the Royalty to the Royalty Holder, on and subject to the terms of this Royalty Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2
Royalty Rate.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
From and after the first day on which Net Revenue is generated and continuing until the termination of this Royalty Agreement pursuant
to Section 2.3, the Royalty payable by the Company to the Royalty Holder pursuant to this Royalty Agreement will equal ten percent (10%)
of Net Revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
In no circumstance may the aggregate amount of the Royalty payable pursuant to the Royalty Agreement exceed the Royalty Payment Cap.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3
Term. </B>This Royalty Agreement will remain in effect until the date on which the Company has provided to the Royalty Holder an officer&rsquo;s
certificate, certified by an officer of the Company, certifying that the cumulative total of Royalty payments equal to the Royalty Payment
Cap have been paid pursuant to the Royalty Agreement, after which this Royalty Agreement will be terminated without any further action
by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article 3<BR>
Payments</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1
Accrual of Payment Obligation</B>. Following the first day on which Net Revenue is generated, the Company must calculate and pay for
each Quarter, the Royalty in accordance with the provisions of this ARTICLE 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2
Payments</B>. Within ten (10) Business Days after the Company publicly releases its financial results for the Quarter in which the Company
is obligated to pay any Royalty hereunder, provided that in the event the Company is not required to publicly release its financial results
pursuant to Applicable Laws or the rules/policies of any stock exchange, within sixty (60) days following the end of the Quarter in which
the obligation to pay any Royalty hereunder, the Company shall provide the Royalty Holder with an Operations Report (as defined below).
Royalty payments will be due and payable to the Royalty Holder as calculated pursuant to the applicable Operations report within five
(5) Business Days after delivery of an Operations Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3
Operations Reports</B>. The Company shall provide to the Royalty Holder a report setting out in reasonable detail the following information
(the &ldquo;<B>Operations Report</B>&rdquo;): (1) the amount of the Royalty payable for that Quarter and details of the Net Revenue,
as applicable, underlying the calculation of the Royalty; (2) the cumulative total of Royalty payments paid to the Royalty Holder under
this Royalty Agreement (including the payment under Subsection 3.3(1)); and (3) any other pertinent information in sufficient detail
to explain the calculation of the Royalty payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4
Audit and Adjustments. </B>All Royalty payments will be considered final and in full satisfaction of all obligations of the Company unless
the Royalty Holder gives the Company written Notice describing and setting forth an objection to the determination or calculation of
the Royalty within [three months] after receipt by the Royalty Holder of the Royalty payment in question. If the Royalty Holder objects
to a particular Operations Report, then the Royalty Holder shall have the right, upon reasonable Notice and during normal business hours,
to have the Company&rsquo;s accounts and records relating to the calculation of the Royalty in question audited by an independent firm
of certified public accountants selected by the Royalty Holder, solely for the purpose of verifying the accuracy of Royalty payments.
If such audit determines that there has been a deficiency or an excess in the payment made to the Royalty Holder, such deficiency or
excess will be resolved either by adjusting the next Quarterly Royalty payment due or by payment being made in the amount of such deficiency
by the Company to the Royalty Holder or in the amount of such excess by the Royalty Holder to the Company if such audit is completed
following the termination of this Royalty Agreement. The Royalty Holder will pay all costs of such audit unless a deficiency of 2.5%
or more of the amount due to the Royalty Holder is determined to exist, in which case the Company will pay the costs of such audit. Failure
on the part of the Royalty Holder to make claim on the Company for adjustment in such [three-month] period will establish the correctness
of the amount of the Royalty payment and preclude the filing of exceptions thereto or making of claims for adjustment thereon; provided
however that if fraud or gross negligence is reasonably determined by the Royalty Holder to exist in respect of any Royalty payment,
then no time limit shall preclude audits and adjustments on past Royalty payments. This Section 3.4 shall survive the termination of
this Royalty Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5
Currency and Wire Transfer</B>. All Royalty payments must be made in United States dollars without demand, notice, set- off, or reduction,
via the transfer of immediately available funds to such bank account as the Royalty Holder may nominate in writing to the Company from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<B>Books and Records</B>. All books and records used by the Company to calculate the Royalty due hereunder will be maintained in accordance
with U.S. GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<B>Operating by Affiliates</B>. The Company will be permitted to contract with an Affiliate of the Company or an unaffiliated third Person
for the operating, licensing or other monetization or commercialization of Company Equipment, provided that such contract is on an arm&rsquo;s
length basis at market terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
4<BR>
Operation of the Company Equipment</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1
Company to Determine Operations</B>. The Royalty Holder acknowledges and agrees that any decisions regarding the ownership, use, commercialization,
sale, or transfer of the Company Equipment, and the terms thereof, is solely a decision of the Company, and the Company shall have no
liability to the Royalty Holder of any kind on account thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
5<BR>
Assignment</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1
Assignment by the Royalty Holder.</B> The Royalty Holder may convey or assign all or any portion of the Royalty upon 30 days prior written
notice to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2
Assignment by Company</B>. The Company may transfer, sell, assign, charge, pledge, hypothecate, mortgage or otherwise dispose of its
interest in the Company or the Company Equipment, provided that, it shall be a condition of such transfer, sale, assignment or other
disposition that the assignee covenants to be bound by the terms of this Royalty Agreement (to the extent of the interest assigned).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
6<BR>
Confidentiality</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1
Confidentiality</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to Subsection 6.1(2), each Party covenants with the other that it will keep confidential
                                            all information delivered to a Party pursuant to the terms of this Royalty Agreement, including
                                            any such information regarding a Party&rsquo;s Affiliates delivered to a Party pursuant to
                                            the terms of this Royalty Agreement (&ldquo;<B>Confidential Information</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            Party undertakes that neither it nor its directors, officers, employees, agents or contractors
                                            will, without the prior written consent of the other Party, disclose any Confidential Information
                                            to any third Person unless:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            disclosure is expressly permitted by this Royalty Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            information is already in the public domain (unless it entered the public domain because
                                            of a breach of this Section 6.1 by the Party);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            disclosure is made on a confidential basis to the Party&rsquo;s officers, employees, agents,
                                            financiers or professional advisers, and is necessary for the Party&rsquo;s business;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            disclosure is necessary to comply with any Applicable Law, or an order of a court or tribunal;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to Subsection 6.1(2)(i), the disclosure is necessary to comply with a directive or request
                                            of any Governmental Authority, securities regulator or stock exchange (whether or not having
                                            the force of law) so long as a responsible person in a similar position would comply;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to Subsection 6.1(2)(i), the disclosure is necessary or desirable to obtain an authorization
                                            from any Governmental Authority, securities regulator or stock exchange;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            disclosure is necessary in relation to any discovery of documents, or any proceedings before
                                            a court, tribunal, other Governmental Authority, securities regulator or stock exchange;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            disclosure is made on a confidential basis to a prospective assignee or financier of the
                                            Party, or to any other person who proposes to enter into contractual relations with the Party
                                            and agrees to keep the disclosure confidential in accordance with this Section 6.1.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
disclosing any Confidential Information to a Governmental Authority or securities regulator in accordance with Subsections 6.1(2)(e)
or 6.1(2)(f), the disclosing Party must use its commercially reasonable efforts to provide the other Party with a draft of the proposed
disclosure for its consideration and comment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article 7<BR>
Taxes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1
Withholding by Company.</B> To the extent required by Applicable Law, the Company may deduct, withhold, charge or levy, any Taxes imposed
by any Governmental Authority on the Company or any of its Affiliates, or otherwise required to be withheld, in respect of any payment
made by the Company to the Royalty Holder or any of its Affiliates under this Royalty Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2
Cooperation.</B> The Parties agree to reasonably cooperate to: (i) facilitate Tax planning with respect to payments on account of the
Royalty; (ii) ensure that no more Taxes, duties or other charges are payable than is required under Applicable Law; and (iii) obtain
a refund or credit of any Taxes which have been overpaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article 8<BR>
Miscellaneous</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1
Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Royalty Agreement shall be governed by and construed in accordance with the internal laws
                                            of the State of Delaware without giving effect to any choice or conflict of law provision
                                            or rule (whether of the State of Delaware or any other jurisdiction).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANY
                                            LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS ROYALTY AGREEMENT, THE
                                            ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY MAY BE INSTITUTED
                                            IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF THE STATE OF DELAWARE
                                            IN EACH CASE LOCATED IN COUNTY OF KENT, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE
                                            JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING. SERVICE OF PROCESS, SUMMONS,
                                            NOTICE OR OTHER DOCUMENT BY MAIL TO SUCH PARTY&rsquo;S ADDRESS SET FORTH HEREIN SHALL BE
                                            EFFECTIVE SERVICE OF PROCESS FOR ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT IN ANY SUCH
                                            COURT. THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY OBJECTION TO THE LAYING OF VENUE
                                            OF ANY SUIT, ACTION OR ANY PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT
                                            TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY
                                            SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
                                            PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS ROYALTY AGREEMENT
                                            OR THE ANCILLARY DOCUMENTS IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE,
                                            EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY
                                            JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS ROYALTY AGREEMENT,
                                            THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY TO
                                            THIS ROYALTY AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER
                                            PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE
                                            THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION, (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS
                                            OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) SUCH PARTY HAS BEEN
                                            INDUCED TO ENTER INTO THIS ROYALTY AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
                                            CERTIFICATIONS IN THIS <U>SECTION 8.1(3)</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2
Conflicts</B>. If, strictly in connection with the interpretation of this Royalty Agreement, there is any conflict or inconsistency between
the provisions of this Royalty Agreement and the provisions of the Share Exchange Agreement, the provisions of the Share Exchange Agreement
shall govern and prevail, and such provision of this Royalty Agreement shall be deemed to be amended to the extent only to eliminate
any such conflict or inconsistency. Any right or remedy in this Royalty Agreement which may be in addition to the rights and remedies
contained in the Share Exchange Agreement shall not constitute a conflict or inconsistency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.3
Other Activities and Interests.</B> This Royalty Agreement and the rights and obligations of the Parties hereunder are strictly limited
to the Royalty. Each Party will have the free and unrestricted right to enter into, conduct and benefit from any and all business ventures
of any kind whatsoever, whether or not competitive with the activities undertaken pursuant hereto, without disclosing such activities
to the other Party or inviting or allowing the other to participate therein, including activities involving activities competitive with
or supplemental to the Royalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.4
No Partnership</B>. This Royalty Agreement is not intended to, and will not be deemed to, create any commercial or other partnership
between the Company on the one hand and the Royalty Holder on the other hand. The obligations and liabilities of the Company on the one
hand and the Royalty Holder on the other hand, will be several and not joint and no Party on the one hand will have or purport to have
any authority to act for or to assume any obligations or responsibility on behalf of any Party on the other hand. Nothing herein contained
will be deemed to constitute a Party on the one hand the partner, agent or legal representative of a Party on the other hand or to create
any fiduciary relationship between the Party on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.5
Notices.</B> All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall
be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if
sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by e-mail of a PDF document (with confirmation
of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours
of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid.
Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall
be specified in a notice given in accordance with this <U>Section 8.5</U>):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Royalty Holder:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 65%; text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orbit Capital Inc.</FONT></P>
                                                                                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C/O Cayman
International Corporate and Marine Services Ltd.</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.O. Box 822, George Town, Grand Cayman KY1-1003, Cayman Islands</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention : Jason Butcher </FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">If
    to Company:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">433
    Plaza Real, Suite 275</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca
    Raton, FL 33432</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    gpursglove@lixte.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Geordan Pursglove</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">with
a copy to:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
    Ross Ference Carmel LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
    Avenue of the Americas</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10036</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
    rcarmel@srfc.law</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Ross Carmel</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.6
Further Assurances.</B> Each Party will, at the request of another Party and at the requesting Party&rsquo;s expense, execute all such
documents and take all such actions as may be reasonably required to effectuate the purposes and intent of this Royalty Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.7
Entire Agreement</B>. This Royalty Agreement constitutes the entire agreement among the Parties with respect to the subject matter hereof
and cancels and supersedes any prior understandings and agreements between or among the Parties with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.8
Amendments and Waiver</B>. No modification of or amendment to this Royalty Agreement shall be valid or binding unless (i) set forth in
writing and duly executed by the Parties and (ii) such modification or amendment is also made to each of the Royalty Agreements. No waiver
of any breach of any term or provision of this Royalty Agreement shall be effective or binding unless made in writing and signed by the
Party purporting to give the same and, unless otherwise provided, shall be limited to the specific breach waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.9
Counterparts.</B> This Royalty Agreement may be executed in one or more counterparts, including by facsimile, scanned PDF and other means
of electronic transmission, and, if executed in more than one counterpart, the executed counterparts shall each be deemed to be an original
but all such counterparts shall together constitute one and the same instrument. The parties agree that this Royalty Agreement may be
executed and delivered by electronic signatures and that the signatures appearing on this Royalty Agreement are the same as handwritten
signatures for the purposes of validity, enforceability and admissibility. The words &ldquo;execution,&rdquo; &ldquo;signed,&rdquo; &ldquo;signature,&rdquo;
&ldquo;delivery,&rdquo; and words of like import in or relating to this Royalty Agreement or any document to be signed in connection
with this Royalty Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form.
Any document accepted, executed or agreed to in conformity with such laws will be binding on all parties hereto to the same extent as
if it were physically executed and each party hereby consents to the use of any third party electronic signature capture service providers
as may be reasonably chose by a signatory hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.10
Enurement</B>. This Royalty Agreement will enure to the benefit of and be binding on the Parties and their respective successors and
permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.11
Severability</B>. If any one or more of the provisions contained in this Royalty Agreement is held to be invalid, illegal or unenforceable
in any respect under the Law of any jurisdiction, the validity, legality and enforceability of such provision will not in any way be
affected or impaired thereby under the Law of any other jurisdiction and the validity, legality and enforceability of the remaining provisions
contained herein will not in any way be affected or impaired thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.12
Calculation of Time</B>. In this Royalty Agreement, a period of days will be deemed to begin on the first day after the event which began
the period and to end at 5:00 p.m. (Eastern time) on the last day of the period. If, however, the last day of the period does not fall
on a Business Day, the period will terminate at 5:00 p.m. (Eastern time) on the next Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.13
Currency</B>. Unless otherwise indicated, all references to currency herein, including &ldquo;$&rdquo; are to lawful money of the United
States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.14
Consent</B>. Whenever a provision of this Royalty Agreement requires an approval or consent and such approval or consent is not delivered
within the applicable time limit, then, unless otherwise specified, the Party whose consent or approval is required shall be conclusively
deemed to have withheld its approval or consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.15
Headings</B>. The headings to the articles and sections of this Royalty Agreement are inserted for convenience only and will not affect
the construction hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.16
Other Matters of Interpretation</B>. In this Royalty Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            singular includes the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            masculine includes the feminine and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                            to &ldquo;Article&rdquo;, &ldquo;Section&rdquo;, and &ldquo;Subsection&rdquo; are to articles,
                                            sections, and subsections of this Royalty Agreement, respectively;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            provisions requiring a Party to do or refrain from doing something will be interpreted as
                                            the covenant of that Party with respect to that matter notwithstanding the absence of the
                                            words &ldquo;covenants&rdquo; or &ldquo;agrees&rdquo; or &ldquo;promises&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            provisions requiring a Party to do something will be interpreted as including the covenant
                                            of that Party to cause that thing to be done when the Party cannot directly perform the covenant
                                            but can indirectly cause that covenant to be performed, whether by an Affiliate under its
                                            control or otherwise; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            words &ldquo;hereto&rdquo;, &ldquo;herein&rdquo;, &ldquo;hereby&rdquo;, &ldquo;hereunder&rdquo;,
                                            &ldquo;hereof&rdquo; and similar expressions when used in this Royalty Agreement refer to
                                            the whole of this Royalty Agreement and not to any particular Article, Section, Subsection
                                            or portion thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Remainder
of page intentionally left blank]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Parties have caused this Royalty Agreement to be signed, sealed and delivered as of the date first set forth
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIXTE
    BIOTECHNOLOGY HOLDINGS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Geordan Pursglove</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Geordan Pursglove</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Chief Executive Officer</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ORBIT CAPITAL INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Jason
    Butcher</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Jason Butcher</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to the Royalty Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Equipment</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Equipment means the Proton Light Beam and all machinery, equipment, and devices used or held for use by Liora in connection with the
operation of the Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes hereof, &ldquo;Business&rdquo; means the business of developing and delivering the proton-based radiotherapy solution called
LIGHT (Linac Image Guided Hadron Therapy) as conducted by Liora.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 134; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIXTE
Biotechnology Acquires Liora Technologies&rsquo; Proprietary Proton Therapy Platform for Cancer Treatment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Located
at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to date
in developing the technology</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BOCA
RATON, Fla., November 25, 2025 &mdash; </B>LIXTE Biotechnology Holdings, Inc. (&ldquo;LIXTE&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq:
LIXT) a biotech company focused on advancing cancer treatments, today announced it has completed the acquisition of Liora Technologies
Europe Ltd., a UK-based company pioneering electronically controlled proton therapy systems for treating tumors in various types of cancers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liora
will become a wholly owned subsidiary of LIXTE. The acquisition includes Liora&rsquo;s proprietary flagship technology LiGHT System (Linac
for Image Guided Hadron Therapy), which provides significant advantages over currently available technologies for treating tumors with
proton therapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liora&rsquo;s
LiGHT system is installed at STFC&rsquo;s Daresbury Laboratory, which will be providing resources to develop a center of excellence for
proton therapy treatment using the LiGHT system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
acquisition of Liora represents our entry in the radiotherapy segment of cancer care and marks a significant step in LIXTE&rsquo;s corporate
growth and development as we aim to fulfill our mission of treating cancer with cutting-edge technologies,&rdquo; said Geordan Pursglove,
CEO of LIXTE. &ldquo;We believe that Liora&rsquo;s flagship technology LiGHT System has significant global potential and could well set
a new gold standard in cancer care, delivering high-precision proton therapy that is scalable and clinically versatile.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
Steve Myers, former Director of Accelerators and Technology at CERN, the European Organization for Nuclear Research, said, &ldquo;The
highly adaptable LiGHT System provides a proton beam allowing the delivery of very high dose rates to deep-seated tumors. In addition
to the unique biological effects, it will also greatly reduce the installation cost and the number of treatment sessions needed, compared
to current technologies, and is expected to significantly increase the number of patients that a treatment center can serve. With LIXTE&rsquo;s
acquisition of Liora&rsquo;s assets, I am excited to see how the Company advances and scales this technology. I believe there is tremendous
potential to turn this into a transformative new standard in cancer treatment.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
plan is to bring the LiGHT system to the forefront of modern cancer treatment and eventually enable LIXTE to pursue a recurring revenue
model through jointly operated treatment centers. The addition of Liora also represents an excellent complement to the pharmaceutical
side of our business and our ongoing clinical trials with LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer,&rdquo;
Pursglove added.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
LIXTE Biotechnology Holdings, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>LIXTE
Biotechnology Holdings, Inc</U>. is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing
and commercializing cancer therapies. LIXTE has demonstrated that its first-in-class lead clinical PP2A inhibitor, LB-100, is well-tolerated
in cancer patients at doses associated with anti-cancer activity. Based on extensive published preclinical data (see <U>www.lixte.com</U>),
LB-100 has the potential to significantly enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIXTE&rsquo;s
lead compound, LB-100, is part of a pioneering effort in an entirely new field of cancer biology &ndash; activation lethality &ndash;
that is advancing a new treatment paradigm. LIXTE&rsquo;s new approach is covered by a comprehensive patent portfolio. Proof-of-concept
clinical trials are currently in progress for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. Additional information about
LIXTE can be found at <U>www.lixte.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statement Disclaimer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. For example, statements regarding the Company&rsquo;s financial position, business strategy
and other plans and objectives for future operations, and assumptions and predictions about future activities, including the continuing
development of proprietary compounds, the planning, funding, coordination and potential results of clinical trials, the patent and legal
costs to protect and maintain the Company&rsquo;s intellectual property worldwide, and the Company&rsquo;s ability to maintain compliance
with Nasdaq&rsquo;s continued listing requirements, are all forward-looking statements. These statements, also including but not limited
to, pursuing a recurring revenue model through the Company&rsquo;s acquired LiGHT system, are generally accompanied by words such as
&ldquo;intend,&rdquo; anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;potential(ly),&rdquo; &ldquo;continue,&rdquo;
&ldquo;forecast,&rdquo; &ldquo;predict,&rdquo; &ldquo;plan,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo;
&ldquo;should,&rdquo; &ldquo;expect&rdquo; or the negative of such terms or other comparable terminology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that the assumptions and expectations reflected in such forward-looking statements are reasonable, based on information
available to it on the date hereof, but the Company cannot provide assurances that these assumptions and expectations will prove to have
been correct or that the Company will take any action that the Company may presently be planning. However, these forward-looking statements
are inherently subject to known and unknown risks and uncertainties. Actual results or experience may differ materially from those expected
or anticipated in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited
to, regulatory policies, available cash resources, research results, competition from other similar businesses, and market and general
economic factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Readers
are urged to read the risk factors set forth in the Company&rsquo;s filings with the United States Securities and Exchange Commission
at <U>https://www.sec.gov</U>. The Company disclaims any intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
more information about LIXTE, contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>info@lixte.com</U><BR>
General Phone: (631) 830-7092; Investor Phone: (888) 289-5533<BR>
or<BR>
PondelWilkinson Inc. Investor Relations <U>pwinvestor@pondel.com</U><BR>
Roger Pondel: (310) 279-5965; Laurie Berman: (310) 279-5962</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  = '0# 2(  A$! Q$!_\0
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MKV#2(?&^I_"3Q=K5C#/JM[?7QMX]1\3:E9V8ENG6TT\165D+:RBAMH_ZLO\
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MW;/WW)<NS/)\NR_+\VQTLPQCPBK8C$RJ5*G-67(IVE4<I--S;U?II8_REO\
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M#[(MQ%X5_9^\1:9:ZAIS6MM<6UG*GQ*^&>GBR\2_$718GEN[6WU3QE'I;,?
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&"K@H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lixt-20251125.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaJObP9z5Z8uekhvWB7bSnK/yQnOGY60iH5fwtWMVMJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:LIXT="http://lixte.com/20251125" elementFormDefault="qualified" targetNamespace="http://lixte.com/20251125">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://lixte.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="lixt-20251125_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="lixt-20251125_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="lixt-20251125_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="LIXT_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" name="WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>lixt-20251125_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="lixt-20251125.xsd#Cover" roleURI="http://lixte.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lixte.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lixt-20251125.xsd#LIXT_CommonStockParValue0.0001PerShareMember" xlink:label="loc_LIXTCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LIXTCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="lixt-20251125.xsd#LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" xlink:label="loc_LIXTWarrantsToPurchaseCommonStockParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LIXTWarrantsToPurchaseCommonStockParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>lixt-20251125_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lixt-20251125.xsd#LIXT_CommonStockParValue0.0001PerShareMember" xlink:label="LIXT_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LIXT_CommonStockParValue0.0001PerShareMember" xlink:to="LIXT_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LIXT_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="lixt-20251125.xsd#LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" xlink:label="LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" xlink:to="LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Warrants to Purchase Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>lixt-20251125_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="lixt-20251125.xsd#Cover" roleURI="http://lixte.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://lixte.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lixt-20251125.xsd#LIXT_CommonStockParValue0.0001PerShareMember" xlink:label="loc_LIXTCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LIXTCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lixt-20251125.xsd#LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember" xlink:label="loc_LIXTWarrantsToPurchaseCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LIXTWarrantsToPurchaseCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 25,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIXTE
BIOTECHNOLOGY HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001335105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2903526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">680
East Colorado Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Pasadena<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">830-7092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LIXT_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value
    $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LIXT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember', window );">Warrants to Purchase Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Common
    Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LIXTW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LIXT_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LIXT_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lixte.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>lixt-20251125.xsd</File>
    <File>lixt-20251125_def.xml</File>
    <File>lixt-20251125_lab.xml</File>
    <File>lixt-20251125_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "LIXT",
   "nsuri": "http://lixte.com/20251125",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "lixt-20251125.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "lixt-20251125_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lixt-20251125_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lixt-20251125_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://lixte.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-11-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-11-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "auth_ref": []
    },
    "LIXT_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://lixte.com/20251125",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "LIXT_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://lixte.com/20251125",
     "localname": "WarrantsToPurchaseCommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to Purchase Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lixte.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-25-024996-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-024996-xbrl.zip
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MC=&(F3HC@*(.^O-K52[3+PP 5#_F>YVLYG1I<P[>[JJ,,T<S1\:@7FD[YP_
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M2T33G'2";AA2^V'9BRUM1T]Q),=55-[4H/>)AB2Z?2765DLL,"(_+=1 6S:
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M=-_65G=S5WBB0.$5,[@H5@O4NUJ3A.JN5@B@XY?D3N )]4*5H<GS*JE6Z3[
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M309T2BWE5IK/E#_D$TZW.>-.9YX3A%A)>M4&*788U;@4*)Q,Q@7@2$,=<W!
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M@P1.C% JX^6%RY5EO;;3V.4YT$6 >EIFYZ#W#8XD[8N%?5)>+@.M-@XNX&*
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M5XX(M,/DU?/0Y(P3LO.$>MIHI/[2P/4:YT6CV2&S",1DM9QJ5<?_+:?N$LD
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MU+MMZ90\L9G2J7?;TJG'M!76.Y7U%V'"%0\1;YI';NNTX]9K+Q'MYGD@P/X
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MC#"(7OGUH-<Z(^23H^%Q!_[P_U!+ P04    "  *B'E;"  BU$\O  !%B $
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MA3 Y'+@8*4SI\1L<@!=P6JC.FLUR9?$G[#\??W'.+N738+[.+>=\3F>8--,
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M\2CF1H+X&_I8#U9Y1+=Q#^E*%_*4;9[U$FJB(!C2S\R3H<*?$E@F*-FRSP6
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M?" 33>QIM(=#59G%/$M]Y4G<_1V_#]O/X5XRASL-@Y&'_DR/V@SO]JEM+OA
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M.NU<]]M_E 3DMVLX_[.VQHQS&!6AXJ4"/(!O_&@]!AV(?JOW1_N4=H,>]_N
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M"-,0>R?[>>3&E<"I]=MPE^',\*=M?;GP1$O+Z71,# K,=5J8ZWWS=SH6^X:
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M-HS4P 2 5>+$_. ,%%TSIARA9K!R2(8D/^9KY%A[KETCUX-W83@>QJX;5ZM
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M]?SDVX6+/4"\M]!2]>O!RWKM/(TXIB..TPA-<]KTO1!0T3"60FV(9,=B/M:
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M\-F+\C%A0%ZQ04S(X8OU&NB\4^2RKN[0$.\B\=DRY#BLU_J4=<!"BTG$Y)R
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MVU7)ZNE)]^P&5<^G%X/W'?CC_P-02P,$%     @ "HAY6]Z'!)+A&0  _J
M  D   !E>#,M,2YH=&WM7>ESV[B2_ZXJ_0_8[+Z47"5?N=[$]KC*AQ)KUV.[
M;"79?(1(2,*$(CD\;&O_^NUN' 0/R7+B9)2,7M6\6!))H('N1A^_;AZ<#?XX
M/VRW#LYZ1Z?P+\/_'0SZ@_/>X<&V^A=^W=8_'QQ?GGYF-X//Y[W?GXVB,-MC
MNSMQQ@9R*E)V(>[8=33E85=]T64W(I&C9W CW'KUV/OVV90G8QGN,;S4_K?/
M,G&?;?) CN$G3X292)X=/@^':;Q_L'WU/0=+Y'B2/3L\.#[LW4_D4&;LY=;N
MP?;QX7<>]X<2:08[>'=Y,7!'V!SQJ0QF>P^-0=>F\O^$FA*MUWG_?P>]=NNX
M?SGHG9Q=7)Y?OO_,SB[/3_L7[V^ZK']QLJ76$0?]4<OYI!2:O?FIB3CI70_Z
M[_HG1[A9E^_8:>^F__[B:-"_O+AA\/GJNO>N=]V[..G==']R4J_[[\\&-^W6
MT<4I.^__T1]8*G]RPFYZU_T>$';"3BXO/N*&'I_W],Y=]TYAF,N3__F9:322
M]B-F_V>>9G(TTU_*T!?X\)VMUS)\.I+VV9![7\9)E(?^IA<%4;+'[B8R$\\.
MK_(DS7F8M5M9!'=[F8Q"MOMZET4CEDT$>R]"D?" G41)'"6<?C[G=^;GFXQG
M C^<BH#?\41TV;F\AZ^.990);Q+"8.,9.XL"7X9CF& _]+:ZC#//>5Z4C'D(
MD_49#_UV2]Q+6)-PS&"V(OFJ6; .?OT\\/_*HWU4.\5]R)C/$_IAH\MDR+@'
M<_%YZ EV)[,)/3!.HEN9PM5INP6/M>NR\Q)_3D0TZC(_@AW #\,92_/A% YK
MO'44!4%T!]/?^X48Z&^2B3E<^[UI!8;Y= :GT-$-,DL71 /V]40D,"GI:4X#
M/G8Y6/&ARYY5#EQPN\N2C.?9)$I@-BD]4J8HGA[>U&[E,0,IW=WI[NS0?RR=
M +.G^, X$2.1)"!#:19Y7[HLY@F[Y4$NV'_M;,&UNRP&8:(;NHWS+>9Z99]U
M@\\J2XP641@O38-9=;K'$4]\DD29@-!$2;K$VM!-Y5% H/Z$^Y'<0()HT7TI
M4IEZB1S"U(:S=@N$O8N7X"()E.4HA(5*V#0"%> %/$UQ<9+2UREL.GR+HH["
M'\[4A408#.M-W!OUQ;!J0< F_%:H*VXCTD]Q=">2%/ACE,//<#E-5?A=_#N,
M*I<5 _@B!3Y7)'7US@G88_C@$@L/ 7*S1'KJ,W>7>,IG\!PX^*8RA T=)=$4
M^!3X&M<#_]W'\59#7M=ZZ%OU$-G"[18<,5(Q ;)0(HQL*9: C0=VX<- IA-B
MMI&\IY_#?#H$V8>+M;Z *X<H+UZ0^R!** <LA&EI=H<+*RJ 'F?&U:P+?$_N
M:I6%\=(2&ZLY%JJ*9* 8;FLU-G/-I%_-I!>7GX 9!LBJ[RZO>UUVW&/] ;ON
MW5R>?^R=TB$*/, SAUE=ZXFL+1]-I\2>><3;_ &.=!\"3 P:'>RURDE[6G#L
M V>R<V7I1*X+%?Z+P\*8*9F>^(4^$Y<5$W,JN"J^47A(7!:L0ZI-SG1M<*XX
M2=J-:+=VM]C!A\-3,9*AI'T^V/YPN,7>:?Z/<S"54LW:Z&J4_ J&AW[))BG_
M/!7@3(&OM6:'52=)*Z(/X)Y.I\@7VMS^8'0/[65:-9^?)RG^F((/C;<M8?#_
MZ"-VS0K?P KA+9P+= 99/FBW*M*N91R.A0Q/S6R"QY^)4KQ9;_>JD]2PW>W6
M*5@2KO _:L\[?./';OMZB[]BBV_(":II^"ZH\B# K;P5P:Q;\9?4Z:#-/8H'
M#0/!\AB^\^RSZVX6!4:5V7A2M1K!E6P.?"K;0MD=:S6RZB19'OOO/)11 OPE
MO#P!D[*!QXI0%SD5]D+EF$DP*&/AD3<4!#/KP&!,/@5Z\/$465K 5&M^6762
M++]<1)GT!.4V&@V.%3][UGO_#7M_F4B8$P_:K3[%6:IFA](6%]&MH*CAB]TN
M>['SXO5ZAU>=)+O#2D%C@KZ6R5G6M;0Z7JF'3*+)47G:VN7\F4FJ$O,?FYOL
MG12!O\>N^%CLPXU_Y1BKA!OVV65,<:H]'$#K_7WV$;<>?F:;FQK9=W#:_VAF
MITC='$99%DWWV!N"(8#!*1+[W7' P:3=A35(HT#Z,*FO6-(Z%L0L\V86Q;34
M]@LSL%J!)UO+37?US+KML\$LADN.$CZ4WCZ[X%.AUO8BPA7;=6_:-G?A+YO.
MWAQLPY(VK.XP$?S+YE# :0Q/C6G'7*K?$(57Y<W0A!<HO]+3W>G@--6V_NQ\
M_@N*KJ/I,?O@MULDB<W:G1(4OE;35;=PH7:_FTC,/) E. 05OTN0 P=%X"3I
MN8^T3P4"B3"-0S%)<"D"B8D/7V)^)_3)T9T.I<Y]4[8C$0%-,$M@QKQ(=1>F
MILJTK ^452?)X4K8_$D4@*IOMXYB3._QH,$AU;^PX8QQ(.3/"#S2F>'1VRB#
MX3V>9OC[/#N%.%$-E9;RAQHSP^K1%W1=Q+TG4ALEV7V[]?;MOUCOWIOP$/3>
M"8_G <-@S@&XR"@O21ZH0,L OK_@J<__TC&:/WCR!;CW_/QDS;2K3I)EVD'"
M$:*(8=A9 Z\RGP-KAEHI*HR@##T9 __J6\V^2^"*6(2*'=5/:SY8=9+J?*!V
MLSF.IA6'DW2EBPFS);0:2<OL4HGBLD"F>.S!#?!L_,MA%[R38 1P,E*H%FS#
M%/7>'GU]\?FFQXZF0(I'I!7Z!S27S( CU=Q+/[T/HN'"7VX$1J#M!5J7XA)^
MCI(O.CE9*,D.7(!+D>8>ZE)$^J$=X"Y.(L814+,.#JTZ21:8\$(#$PK(#)IH
M1],H#S.%41C<81 XRE/\@1"-XA9TW20/?30=.R^Z_][9V7#2$%6\2@,<% ';
M&L53Q)W;+3 "M5@N8Z]N:2G]I3;F5^:UE\1KX N?&N] <1A\8_V%PON(N?11
M+1:,M1IIB/5N+[?;KVBW/RI$]#4!XK1" 65@#/@"H;I@?UE'<#A3N0/D.Z/[
M'= >::9:3K7=JMZ2EH!^BMG"*$.&@_6062!\<ZII,+?!\D58!X*YL]#\"AZ!
M^"N7"6'368#5*>H(703]WVJWSJ([4*%)EPP T'E!!,-P96<LL1JH/*,\ S<_
M1-.A6].NEJHNN3%PK?)D1B.93#DN#\V>DD'XPUFQ&76O#/X+W>&6S#=W64=N
M,!YD"$-.F#8AN(^N&>R.LJ<-FMZ!21(&GE:<C26>,P^D(/%Z.PJ?"D(M@[$U
M'^F),\.IT;42QO&*2VE)9+G0(]$[#R0D.(X?>3F&/<BMQ"T#J0@59V0.@;#:
MP(IJ4S5!]>6>NWHPD03G"1.E ">,I;F2CQ,A<'SEHL)6Q"8BTV")K0VQ%2?)
MJLO7I"ZO>?AEGYU+4"L^SW2*=GV^??V&[3[M=G7X1KOUJ2)XOD1 ]S WA6%8
M3 3B3GB=H-A*C(J"VQ3D1J^ 'TD:-8\;;&2,Q@I2/+=P2YCQ9(;WR-!^!"6!
M>GZ)$T,=" GPUAZIY508= =^KZ DK$"2["L-"9.,.1T%-AA6<FF5/S #5:7T
MHT*:) N0ZPV> &K-+AZ?J(D)B]2EB:9-PR\X!-HM*@W H[P$:\%G.?0N?$JG
MCLER2N347%R\3:5(3NGK=HN&+  T#@KG<6O37; X#U%DG/>%)-V(RL:[)*V5
MSNHHG2%PU8<X4N;&$AIE\RLU"NNX-G;I%')XO=TB<UR9,86_9LQGK,\<JW'B
M) )^S7@AP8[=7Q.HKJY24XX?&*V:!*U.ZP2!_KOE,J#8/)K2)3V,1:)P5UID
M)F  E3VE98SYC*PH._\I]X41*&>:->V(\I@(GEH$I@3E$]V!"9A.9%Q4BZ.?
M0&$4M!,]GDX8. L\L#*KLG0?399N254^$0%Y&U0CI+;@GV#C+< JO%C#$KX-
MEO!B#4N8S]@_I#_2C_8UWI"O4<:!@L*G?DG+N*?S2]&TIUMU3?$B![G><?MT
M%),HSA@;FI@[ _*'FQ'SZS*XU;9FT(4JL5_*>*;Q9KB7)K:'L<(;!W 24MVZ
M%TWC0,YKWJ*.9)D64.6N\L/P,H.#904,UA@SQ$D+67[*P7[6!<V1G6L1ST'C
M0O-X1A7V,&7L$C%3]@S./HS"36HTD9+)4N5>;;-WRU@87>5<(R@D0'?98E,@
M[S((HA3OU*+HV% J'&MDGN0:EH1B5X[$DM&CBK:I'K7BQ-%&<-8TO J+*7VA
M'+-9<X>"QK4W;HPR#.WJ=A_Q".->@8'F8P:_\)H<A43U$, 3S0_6'8$6/CG-
MARF=G$WZSCR^:*I 84F3+%8]2(K+I>G7H/8!Z:4+P<?%^[ 1B Y9E^BA'PN&
M9+X(Y"WM*CZ_>7-J_%#OHV0O5K!QQT-LM_HC['I2N<8I+3&M)IH&-W'K\KW6
M''<H0@9:0(+NUN/0 !/P,4CJFS40JGJ?VDL!QT>LSN%=TVT%3'6UQD/5-N=A
MYL+N5F<:_%3**-CT )Y5.=Q@VULY,>=.N@$78B<!]* PP)X;A;28I1LV+P\#
MT"XJ+E0K#YO[(#NZ\)7[@O L;)P3N2(G#;O2 CE\IDC6*UVEKMWZ*MI UTSC
M#)2G4P3?P"U&L)06J^= ]*14.-WC>2JT9%F^Z*J]L<Y4UYT\A6R&4?1E$Z8/
M[C$A*U7LOT1596H:=69H@),A)R<P!%;%W'FF^A)1*BF[BUCGQ89%%)WR65HA
MVD&@5>C_6SV_)S8+?CT[9UBU<UA1#+K%>LN9'58?>@X0@HP+!<ZM/7W-$RM,
M4,=3/'%>;OA2]L00$)&A2653KCR<8>^RL6-:9 G&Z_ /+D-AFM-4[9>Z4J+3
M%$ZW=@MXBGM%^MI1Z',*C>?'S4V.]$ZFU)3->'XJ%+91,+%NEV;H@)4F_'@H
M$%"&!&%'JQ".2J%CWX4FK!I)=E +_MU0U&<1XN&:C,-2]H+RVD,1"E#U$E,%
M*HA7#:XIMP/SN*.1!+\##P6=^-##QS AW,>[2034%T]D14RP.O9=E&,4#S9@
M/$[$F *!QIE!>  .; '/&-FT_6'<UI0O._Y&L3<V/(FSLYB](X_"J+MO7[XB
M X>RWHC:*EMY[O656*]-JR""&NY\1<AI PZHK#4=QLK9:88,E):AH_J1X154
M08"KKBDMFR[MUH**^ IC;-1Z#18[<FEWI!# >AJ''M@L.>T6&H8%KS\@0TOP
M;"$;%-E%:WDH9N3>&G"[>2+8&@$]4K7] XMLQ!2.!#86692"+\J" SE23(8[
M![//@TQYDO9Q:CN-C?' (FVH5D7N#B%NHY'9+4&V6:'?A*UO9.,2WQIG2<'N
M5>7(. ^X:0P93?-@K("#F6O=.RZY\919H/IT@<'U9A>!W:D6+^U!:6>Z;E%W
MR1, /L6(/[64](7^&Z]L6H!VJ]R_4H<FJI&)KFF"YC/;**UQ/8NG*1N2*1-2
M[5]J2AGT EI1)$_$P>F4!,B533D%/PGU&F%6$&HREK?X@W:1])JX%19SQ+GY
MV, 6!0_D,ARN-'N^(**C^ M//AGFM&=H(,^VV%&H-7?3=K5;=]*!>A%M"(12
M4H5#OME-,\+\JU50/0L57Y _:1S)>3&4ABG'/.'CA,=%356[!1-/L\1H23F-
M _(HC*>LP42%BB&FI;9SV#,.Z0:],"VEQ54+C^HZ9>B])0GM87DR'4R74PXL
M2NA2<TXK_T[YOD"Q62-*$N*\$<!N@$?$%#!O.DX>4!^F=5YAKJBHQ91_P14Q
MX'E<]%BO!YPYUBB@;4QE0CH?;H.5AD,7^!418@Z?TI85XJ*VQ17&8GP35;.+
M8CQWXB5BJ@+G;O)LR]MEKC76B,PKY GWH:%D*=9=NM6CW?A?V7AB'70NHU!-
MNOA^0^/1FB5:B4ECT90^[G0/9&N@+#0J];%ONG<OA-_I<TE;$V7MU3":J\=<
M;9/.LS6X57GB'HPB&M+7TW@0&:@$0 ]N#S*0^MP3/D814$1I0IL@A9O*?1MR
M$(RN460/&IYZWE%2V#'N9B,_.)619="(6S*)&Z1L^3F69&F#FT,41;_UIC(W
M_+Y2Z=0ASIGR>SG-IYI6"H\J8JL($[? KA2(5H$J<S+%2/0$=VZHY=,I*&2F
MGO 70Z0\E-=^N<YK?UM>^^4ZK[V&5CT4D/%50$:IYANJ7D>5>U(4K:N03+\!
M3H7G*VIK&$(?M'.RC'1(P=D24,0Z$%CBC!WJ*^&_AOXM5%I:G&X:OID/5;U,
MNHR7K9#C+( 5AQE6CR>-AE=%^G!WX9.#>P<V)B=,>2((UNX6^6\\8NQT"B=I
MP^#,@MSI4-30*@)+JA.:+*+Y1VFY8,+3I9#I CRE(%N:4KXVC5$_%@M,&/C-
M$JA%'Y-JUD>).99'VECHW&^8<U_ .%%23F$]: YTP!+209 ,/94\F=FM 0<?
M2"RM=+OE.FP:ST:'LG(+"8<Z4U,"B8FFR,6/GM1B!U'%(&@\Y745O2 4BFZN
M\6IF >SF.F'U(<A^L[\7]EO)4*$9M%N^?4,$NDF8A]4])5!6LDD2Y>.)9C,^
MC&[769-5)J@CE$*^=IJD%V5C)DK@?0FCNT#X8Q/1;I9C&YNS$)#EH]I@[<N1
M#I^-T?%-E-&.]K:.'6-@#2948O=K,)[9[JM76'IE(%*E=WK05. ;CGF<*4;2
M5,C9=I4?"9_>?%0T;*37GOS@Q,Z:21<QZ4BG]GC@F8"D8M(C#$TYW[H^<>'!
M-V*.0X$\FY&);0H)S7>[V[L[.P<W'ZX.L\G!-OZK7Y9 ;7FH<+H"75@KN14F
MJ#.V2DXDM]P8%#:!^^&PAF?PX. *>9CI[!,6 6K55PX@54,R#RF^)IL3-9>.
MG9L0 J';P >7/AS1S9&7[F*XF\JMC&#>].HBPKMG_!Z7">PK#&=0!>\$S=1F
M *D-9VB(?1WT,<H3RJ[,7ZPZ<@UC?IF:#6Y:NT4JV[[DRM>)!]PH_  &Q@@C
MG2BD3684^@_E/&-4>MO)$C&9&(W>QQU6Z[-A=61[HF3[2M>78+LH9//"B"DU
MPM#9Y9C/*'@Y+I6DN!7I*!$8$%-"@^!!O$A7L:2F?\Q\""6.U)#4+,62*^7L
M6_"4*KXP&ID>,!,S>)?5ZX$L&JR6+"$H5HUDSOP<=(<*V2(JBW1-%[.&>6(L
M(QOW)PRPP%AG'\-1Z&Q?HS.0TP+<8LKF791,V:?-MU06'JK.8W&"/H:]I]V:
M<]-O*E5N'8UYZ+(8DT7H_J"20:)U93C69J)!-XU5/ED")_'$O.0H45'<$:X.
MOP>Z!<65.T<;5LO5V_8UO0NI<URYH[:]^S;'V&43TW1 IX')5M"[Z3GYAX4X
MQ_GYC K:T2P-4HCIFSR;,3=<#;]SA62R6E[/Q2P.=D&ZC8);DZP1#H16<]=L
M3C:"7F[&P<-T6C;0X"7 =@4@68,8JR.LW;*Y$IU/U$.7;3@=S\9[BHRB0H;0
MNHBT@#^J9V&XFX[*!A@G^;FJ=DRMBIZ%LYK4K@F?8=]55:0F4WA*.BH"%?7'
M&T2MNSWXL*$0(<UJ;3ZN,$$=:8*6/,NI=::3+E'G#%6+JC!7R8A8!LRL0HQ+
MX701 H)\7=0]Z"QJGD78:4358.M?%]7LF/KIC6J,IP*&TO5%J)YUD:;*$19
M&SV)Y4KB/8()$.B H"I8$4*IR3A33=ETIQ*-K(DP.BDP(C4?)(R(*7T,*)O4
MX&;FADAI!)WWMY@0G3&GJ:FD8(* =BG2VC4E])VMB 5[.C,]:3#D";HYFU7
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M)Q,I1FI^/54!"5KE$D%K&+0L;V:A7+;)^OXEW,L%,9+7SGMMS[$*9QTH^8I
MR>O'!TI^U5#&]O'EZ>=#_.-L\,<Y_/'_4$L#!!0    (  J(>5L?!PT!] T
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M/^OT5@OV\XM.]Z(.P/?.& C/'DA(5JJPLPXK;6_JK]C9$>N]:ZT63K%#(#P
MZHT>XE*J5:JKA<PJ,@2:@(H]8!T^L1V/;>+?#/[F*BC\W/48OX$YF4.ON?YJ
MGZ6%ZTY*N)Z3 1E$#S*EK.Y5!_#O['*'_Y24%0&WMQO&U-O7T:2'MB-=G<T
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MW(/#TRN^GW\6=;8'RF(AA]5 0F*RI,0TYDI'X!!FW.2:!_+0LBF4ZX-QA*T
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M> DE8)W;^]/87-!U[G&*B)%0GP.(EK1ZQ07QCNLQG3Q\P>4;"0^<,$H"XWJ
M%\I#X\@MA:!YK"-(2YIV9&%C;F_DT8N<9L##8S!QL"=&7C0-]!'T/@ANPUFP
MA9LD=XR/!&Z[.XD]R[&FA(ZU&*B%F$"(/8Y) ^&R=H6)"IOFN@$'!0Z]GW?)
M*9%++IOQH">'B73@/4V$/# 9F_[@TPD,&=K/")CJ>8[1]X7^A_8:N9DEF^>
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MW]7[Z)N>SI/X7TR^Z.5<(?)]22*NU9Y>5I]3W*(CXA;S!+R]UAV*U34Y/@?
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MKE,D_+K] B&F3)O88C@KW83PPSGN!F2-F1GJ'2_I*(MOWPIAJJ=->XE-S]K
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M-7Y0($<U;XSS,@@$EC+YS\35+Y/%8MX",2#4X ,P1_4OA&YPG 2#5DHP*)?
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MW"H*HO7;G!E)@@HM:HH=8S&C21S%>9RN/O"+3Q9C6ZUL(E= P 85#:8B"!1
M6T8FETJ(E-(Q!-=,YKLBO"'D(D"119)=W=Q81_LVL2LHN@TK.&!E$)!TVM-A
MX0'#J!:!BA D8_QB,\VR+6%/@L<2X@DAT#P DJ$/$2?(9"=41:!/MF8DVO+Q
M\7$\6<SCW$A"9Y<X&Y, <]6(I.T/@@W E,Z"W"<2O(XG/RY^0BK*<?-?TCG#
MXD4!L\?U@B9 ]BFKRA4$+185!Q9)$"C OG0:+BDJI:C0^LA.U3!KJ8ZVWQ4
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M[?WE]4T7_!/?K#;QOQ8X(WS+_P%02P,$%     @ "HAY6[!>]Q ^"   1&,
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M$J^S=D&@:?+!?)M]8W_8OWE@COP#4$L! A0#%     @ "HAY6_?6C>]TE
MZO #  H              ( !     &5X,3 M,2YH=&U02P$"% ,4    "  *
MB'E;"  BU$\O  !%B $ "@              @ &<E   97@Q,"TR+FAT;5!+
M 0(4 Q0    (  J(>5O>AP22X1D  /Z@   )              "  1/$  !E
M>#,M,2YH=&U02P$"% ,4    "  *B'E;'P<- ?0-   T.@  "@
M    @ $;W@  97@Y.2TQ+FAT;5!+ 0(4 Q0    (  J(>5N4*\V7>R0  '@$
M 0 +              "  3?L  !F;W)M."UK+FAT;5!+ 0(4 Q0    (  J(
M>5NX.25XP0,  .<.   1              "  =L0 0!L:7AT+3(P,C4Q,3(U
M+GAS9%!+ 0(4 Q0    (  J(>5N1&2(]\P@  *IH   5              "
M <L4 0!L:7AT+3(P,C4Q,3(U7V1E9BYX;6Q02P$"% ,4    "  *B'E;68F)
M6N,+  !LD   %0              @ 'Q'0$ ;&EX="TR,#(U,3$R-5]L86(N
M>&UL4$L! A0#%     @ "HAY6[!>]Q ^"   1&,  !4              ( !
M!RH! &QI>'0M,C R-3$Q,C5?<')E+GAM;%!+!08     "0 ) " "  !X,@$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:LIXT="http://lixte.com/20251125"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lixt-20251125.xsd" xlink:type="simple"/>
    <context id="AsOf2025-11-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001335105</identifier>
        </entity>
        <period>
            <startDate>2025-11-25</startDate>
            <endDate>2025-11-25</endDate>
        </period>
    </context>
    <context id="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001335105</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LIXT:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-25</startDate>
            <endDate>2025-11-25</endDate>
        </period>
    </context>
    <context id="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001335105</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LIXT:WarrantsToPurchaseCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-25</startDate>
            <endDate>2025-11-25</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-11-25" id="Fact000003">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag contextRef="AsOf2025-11-25" id="Fact000004">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-11-25" id="Fact000005">0001335105</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-11-25" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-11-25" id="Fact000011">2025-11-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-11-25" id="Fact000012">LIXTE BIOTECHNOLOGY HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-11-25" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-11-25" id="Fact000014">001-39717</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-11-25" id="Fact000015">20-2903526</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-11-25" id="Fact000016">680 East Colorado Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-11-25" id="Fact000017">Suite 180</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-11-25" id="Fact000018">Pasadena</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-11-25" id="Fact000019">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-11-25" id="Fact000020">91101</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-11-25" id="Fact000021">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-11-25" id="Fact000022">830-7092</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-11-25" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-11-25" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-11-25" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-11-25" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">Common Stock, par value     $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000028">LIXT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-11-252025-11-25_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember"
      id="Fact000030">Warrants to Purchase Common     Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember"
      id="Fact000031">LIXTW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-11-252025-11-25_custom_WarrantsToPurchaseCommonStockParValue0.0001PerShareMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-11-25" id="Fact000033">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
